WhartonMBA Program in Health Care Management 2015 RESUME BOOK Contents Program Description . . . . . . . . . . . . . . . . . . . . . . 4 Curriculum . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 5 Graduates . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 6-27 Internship Sponsors . . . . . . . . . . . . . . . . . . . . . . 28 Health Care Program Mentors . . . . . . . . . . . 29-32 Administration . . . . . . . . . . . . . . . . . . . . . . . . . . 33 Faculty . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 34-35 Thank you for your interest in the Wharton MBA Program in Health Care Management. For further information, resumes, and appointments, contact: June Kinney, Associate Director, MBA Program in Health Care Management The Wharton School University of Pennsylvania 3641 Locust Walk Philadelphia, PA 19104-6218 215.898.6861 | Fax 215.573.2157 email:
[email protected] For information on the Wharton Health Care Management Alumni Association, visit www.whartonhealthcare.org For detailed information on the Health Care Management Department educational programs, visit http://hcmg.wharton.upenn.edu/ 2015 Health Care Management M.B.A. Graduates The University of Pennsylvania was founded by Benjamin Franklin in 1740. Although the University carries the name of the Commonwealth, it is not a state university but an independent, private, nonsectarian institution. As one of the country’s earliest educational institutions, it has consistently initiated advances in teaching and research and has steadily generated specialized fields of higher education. Penn, as the University is commonly known, was the first American university to form departments of botany, hygiene and public health, surgical research, and research medicine. The University School of Medicine, formed in 1765, was the first in North America, as was the teaching hospital founded in 1874. The world’s first psychological clinic was opened at Penn in 1896. The Wharton School, in the same spirit of innovation and excellence, was the world’s first collegiate school of business and management. Founded in 1881 with a gift from Joseph Wharton, the Philadelphia industrialist and philanthropist, the Wharton School undertook the pioneer steps in elevating training for business significantly above its previous level as noncollegiate commercial education. In 1921, the formation of the Graduate Program signaled the advancement of business administration at Wharton to the highest levels of professional education. Today, the Wharton School has more than 270 faculty members teaching in both the graduate and undergraduate divisions and conducting a continually expanding volume of research. The 1,700 students in the master’s degree program may choose from among more than 200 courses and over 18 majors and concentrations, a variety reflecting the fact that the Wharton education complements the career goals of the individual. This brochure is provided to introduce you to the 2015 Wharton Health Care Management Program graduates. We encourage you to consider these individuals for employment. 3 financial services. managed care. hospitals. corporations. one of the foremost innovators in private health insurance in the United States. By combining the skills of the Wharton disciplines with sensitivity to the needs of health care providers and recipients. is designed to provide managerial and technical expertise to students interested in the health care management field. biotechnology and medical device companies. Both Mr. University of Pennsylvania faculty and staff work together on issues concerning health policy. He was the founder of Colonial Penn Group. and federal. Established in 1967. pharmaceutical. and local government. entrepreneurial ventures. Inc..Program Description The Graduate Program in Health Care Management is a full-time two-year MBA curriculum offered by the Health Care Management Department of the Wharton School. Many of these MBA graduates now hold positions as chief executive officers. insurance firms. the principal educational effort at the Leonard Davis Institute of Health Economics. financing. Davis and Mrs. private health industry. pharmaceutical companies. and other healthrelated organizations. and other key decision makers in health care organizations. 4 The Leonard Davis Institute of Health Economics (LDI) is an interdisciplinary center for research and education in the organization. contributing basic support for the activities of the Leonard Davis Institute. Through LDI. health insurance. The program. The Program has produced graduates who have chosen careers in hospitals and other medical institutions. directors. the Institute appropriately bears the name of the late Leonard Davis. state. consulting firms. . Sophie Davis were generous benefactors to the University of Pennsylvania. the Wharton MBA health care graduate can effectively manage the delivery of health services and products at all levels. and delivery of health care. a company that has pioneered in insurance for older Americans. or to pursue specialized knowledge in areas such as health care financing or within specialized segments of the health care industry including managed care organizations. Market Structure. MBA Electives Opportunities are available for the health care major to pursue a second concentration in fields such as entrepreneurship. statistics. or operations. strengthen leadership training. pharmaceutical and biotechnology companies. Graduate courses are available throughout the University. managing people and organizational design. The Health Care Major Courses and Electives These courses promote an understanding of concepts. and issues involved in the organization. the governmental and legal environment of business. Health care electives are selected consistent with individual career objectives and interests. operations management. specialty services organizations. management science. hospitals. and strategy. and delivery of health services and products in the United States. The Wharton School’s core curriculum is designed to increase crossfunctional integration. financial and cost accounting.Curriculum The Wharton Management Core All students are required to complete the Wharton Management Core. institutions. and Health Care Delivery • Health Business and Policy • Health Care Marketing • Healthy Policy • Legal Aspects of Health Care • Management and Economics of Pharmaceutical and Biotechnology Industry • Medical Devices • Management of Health Care for the Elderly • E-Health: Business Models and Impact • Management of Health Care Services Businesses • Health Care Entrepreneurship • Private Sector Role in Global Health • Health Care Services Delivery: A Managerial Economic Approach • Advanced Study Project The Health Care Summer Internship The internship is a three-month management experience which provides the health care major an opportunity to work with a senior executive in an organization of particular interest to the student. Required • Health Services System • Health Care Field Application Project Electives • Comparative Health Care Systems • Financial Management of Health Care Organizations • Managed Care. and introduce new courses on key management issues. Fixed Core: • Foundations of Teamwork and Leadership • Marketing Management • Quality and Productivity • Regression Analysis for Business • Microeconomics for Managers • Management Communication Flexible Core: Accounting • Financial Accounting or • Financial and Managerial Accounting or • Accelerated Financial Accounting Finance: Corporate Finance • Corporate Finance or • Accelerated Corporate Finance or • Introduction to Corporate Finance Finance: Macroeconomics • Macroeconomics and the Global Economic Environment or • Introduction to Macroeconomics and the Global Economic Environment Legal Studies & Business Ethics • Responsibility in Global Management or • Responsibility in Professional Services Management • Managing the Established Enterprise or • Managing the Emerging Enterprise Marketing • Dynamic Marketing Strategy or • Strategic Marketing Simulations Operations • Business Analytics or • Information Technology and Business Transformation or • Innovation or • Operations Strategy • Communications • Advanced Persuasive Speaking or • Advanced Persuasion and Data Display or • Pitching Your Business Global Immersion Program The Wharton Global Immersion Program is an optional half-credit elective course that provides first-year students with an in-depth exposure to international business practices and first-hand insights into a foreign culture. finance. marketing. and long term care organizations. marketing. extend global experience. 5 . finance. The core curriculum provides groundwork in basic management disciplines: economics. medical device companies. financing. New York. 2006 A commercial marketing opportunity in the biopharmaceutical industry. Pinpointed margin contribution from surgeries using financial and medical data. and branded consumer products. Bondo.B.500 students. RI B. An opportunity to build successful health care businesses through an operational or strategic role. Ross School of Business. 6 Mount Sinai Hospital. MD B. Arlington. one of Pfizer’s most highly anticipated new drug launches. Boston.S. 2009 neil. cluster analysis. 2010-2013 Member of the private equity group at Soros Fund Management. Developed a consumables marketing toolkit that was showcased at an industry conference in August 2014. distribution strategy. Created health education initiative reaching 2.agarwal. physician marketing campaign to announce the potential US approval of Palbociclib. As part of a 16-person team managing a $3. Finance and Accounting. NY Summer Associate.upenn. leading due diligence sessions. Economics / Engineering. Providence. College Park. entertainment. customer segmentation.adkins. CA Marketing Intern. coordinating third-party advisors. G. Capital Management and Advisors. Candidate. U. 2012-2013 Consultant. Summer 2014 Designed and initiated a plan to evaluate and address cost-driven attrition in the United States for the Diabetes Business Unit.wg15@wharton. MI B.edu University of Michigan. Ann Arbor. Developed data analysis tools.P.5B portfolio.S. Evaluated and executed potential opportunities as the sole associate resource in the organization with responsibilities including: developing financial models. NY Marketing Summer Associate.A. and preparing investment memorandums. Presented recommended content strategy to Business Unit Review Committee to gain alignment on strategy from a regulatory perspective.edu University of Maryland. Soros Fund Management. Mathematics.wg15@wharton. 2016 david. Worked with a creative advertising agency to drive the execution of individual tactics and presented proposed campaign directly to the President of North America Oncology. the private family office of the Soros family.A.F. Simon-Kucher & Partners. B.upenn.. Summer 2014 Recommended staff allocation modifications that increased OR utilization by 30%. VA Health Care Analyst. Deloitte Consulting. NY Private Equity Associate. NY Private Equity Associate.S.wg15@wharton. Cambridge. Led project teams of 2-9 consultants on engagements providing clients with data-driven strategic recommendations on topics such as launch pricing. MA Senior Consultant. Pfizer.Matt R. and medical device industries..upenn. Synthesized primary and secondary research into strategy white paper to be used by other large foundations.edu Brown University. payer contracting.A. New York. multi-channel. primary responsibilities were to evaluate new investment opportunities and to manage portfolio companies in a variety of industries including telecommunications. An opportunity to use my strategic and operational expertise to improve value in health care delivery. Presented reports and key recommendations to client teams. Biochemistry. including senior management and C-level executives. Only analyst invited to aid senior management in new business development. biotechnology. Adkins Neil Agarwal David Allen matthew. High Distinction. forecasting. Peace Corps. 2009-2011 Advised 4 rural hospitals on operational improvements and recommended changes to Health Ministry’s $1. Medtronic.allen. Created the business case recommendation for launch of a new infusion set in early 2015. and patient assistance programs. Catapult Consultants. Analyzed ER care processes to reduce wait times and increase revenue. New York.. 2011-2013 Worked with Medicare & Medicaid on multiple engagements targeting care quality in hospitals and nursing homes. NY Summer Administrative Resident. Summer 2014 Led the development of a full. created client trainings. 2008 Harvard Kennedy School of Government. supported IT system design. wasteto-energy and healthcare. Kenya Public Health Advisor. New York.2M district budget. New York. Summer 2014 Advised a major foundation in setting organization-wide strategy for $300M in health-related funding and investment. MA M. Leveraged quantitative analysis techniques including multivariate regression. 2009-2011 Pricing and marketing consultant for clients in the pharmaceutical.. 2007-2010 $250M private equity fund focused on media. . and conjoint analysis to drive strategic recommendations. messaging strategy. Northridge. and private equity firms.A. 2013 Self Health Network is a readmission avoidance-focused health care technology company. World Economic Forum. Lancaster. 7 . M&A and strategic advisory services to health care provider and managed care companies resulting in more than $1.A. Focused on client service and business development for finance and health care sectors. New York. and growth financing assignments in the health care and information technology industries.. CA Chief Strategy Officer. geographies. a provider of video remote interpretation (VRI) services to the health care provider market.brallier. Political Science. Led investment analyses related to platform company investments on behalf of private equity clients. 2010-2013 Provided financial. including advising clients on personal long-term goals and negotiating deal terms with clients and investors.edu Franklin & Marshall College.. 2009-2013 Managed merger and acquisition.atwood. New York. McKinsey & Company. and coaching consultants and client executives. 2007-2009 Originated and traded credit products for a Merrill Lynch proprietary fixed income trading desk as well as thirdparty clients. PA Senior Associate. New Haven. Summer 2014 Developed product and go-to-market strategy for the launch of a $5B consumer-directed business at a major health insurer. Bank of America Merrill Lynch. CT B. Worked extensively with multiple portfolio companies to amend cash management strategy and forecast revenue bridge projections. New York. Brallier joshua.upenn. Ministers of Finance. Cum Laude. business development. Summer 2014 Evaluated more than two dozen investment opportunities in healthcare services and IT sectors for firm’s $150M second fund. NY Associate. Belsky Jonathan P. Falcon Capital Partners. 2016 brian. The opportunity to build successful businesses through health care focused private equity investing.8B in completed transactions in 3 years. Merrill Lynch & Co. Health Care Investment Banking. Responsibilities included leading successful fundraising effort. Washington.A. Booz & Company (nka Strategy&). including Warburg Pincus and Parthenon Capital. and industry leaders on health system delivery and financing. Health Enterprise Partners. MA Engagement Manager 2013 Senior Associate 2012 Business Analyst 2010-2012 Research Analyst 2008-2010 Led large consultant and client teams across over a dozen projects for leading life sciences.wg15@wharton. Designed and managed complex projects. Geneva. representing over $1B in value. cultivating sales pipeline. developing new product and preparing eightquarter corporate strategic plan. Morgan Joseph. San Francisco.wg15@wharton. Tax-Exempt Capital Markets. Philadelphia.. and execution of merger and acquisition. 2007 An opportunity to build successful companies in healthcare through strategy. 2007-2009 Participated in the origination. Health Strategy Group.Joshua Atwood Brian P. 2008 Harvard Kennedy School of Government M. and general advisory assignments for clients in various industries. and cultures.edu Wesleyan University B. NY Summer Associate. Economics and French Studies. Albright Stonebridge Group. Self Health Network. Nashville. Worked closely and built relationships with senior client management across industries. financial services.upenn. An opportunity to develop and execute innovative strategies to improve health care ecosystems. creating client deliverables.edu Yale University. Determined company and product positioning through analysis of consumer data. New York. Finance / Accounting.belsky. NY MBA Associate.P. DC External Adviser. or direct investing. Designed an interactive financial operating model for the future-state business. strategic advisory. Directly managed client relationships during several sell-side transactions. conducting qualitative and quantitative
[email protected]. 2014 Advised multinationals on how best to navigate complexities of investments and operations in emerging markets through commercial diplomacy and management consulting..A. NY Analyst. TN Analyst. Boston. analysis. Facilitated CEO and Minister level discussions at the World Economic Forum Annual Meeting at Davos 2012 as well as 10 other half-day workshops. Candidate. and market trends. 2007 jonathan. Switzerland Project Manager 2012 Developed strategies and policy recommendations for Ministers of Health. competitive offerings. Transaction experience includes preferred equity investment in InDemand Interpreting. PA B. fairness opinion. High Honors.wg15@wharton. PA B.edu The University of Chicago. MA M. Worked across sales. review. Philosophy. Cambridge. Turkey Product Manager.burtoft..P. Led the product launch for Perjeta and served as the main commercial regulatory expert for cross-functional teams. Analyzed client data and made recommendations based on customer lifecycle analytics. Clinton Health Access Initiative Nairobi.A. Managed $3M grant covering programs and staff in Kenya. Perjeta. Summer 2014 Evaluated and provided recommendations for potential commercial partnerships with companies filing NDAs for a drug to be used in combination with Revlimid. Summer 2014 Developed market-entry strategies to support Infosys’s expansion into the US healthcare and government sectors.. as well as increased spend/attention to this group.Colin W. Nigeria. Developed Turkey’s first telemedicine project empowering physicians to track patients’ records remotely. 2011-2013 Analyst. including the cholesterollowering drug Lipitor. 2008-2014 Worked for five years full-time and for one year on a contract basis as the promotional review committee (PRC) lead for multiple brands. Used my commercial regulatory expertise to lead the creation. and Liberia. including Boniva. 2010-2011 Advised government officials in the Caribbean and Sub-Saharan Africa on opportunities to reduce HIV treatment costs and increase quality of care. Bioengineering. reimbursement. 2016 alexandra. and Tarceva. Pfizer. pricing. Infosys Limited.and physician-focused promotional tactics. etc. Developed launch plans for two different products (Eliquis. and customer lifetime value models. Honors.car.upenn.A.A. managed care. commercial training. IL B. Spearheaded an evaluation of the current strategy for marketing to hematology/oncology NPs/PAs and recommended specific tactics. The program was nominated for a RethinkD Award for out-of-the box thinking for the betterment of the company. . Infosys Public Services. and marketing strategies by working closely with cross-functional partners. and ad agency collaboration for both consumer. 2007 Harvard Kennedy School. Improved accuracy of measurements allowed the company to invoice and collect on over $10M in outstanding revenue. next-product-to-buy. India Intern. IL Lead.upenn. Measurement Team.wg15@wharton. Collaborated with procurement agencies and regulatory authorities to accelerate the introduction of novel. Turkey B.upenn. Accretive Health. 2009-2012 Project Manager 2008-2009 Responsible for developing and executing cardiovascular products’ business plans. Identified growth potential in diabetic patients for Lipitor by consolidating market data with customer insights and led diabetes projects resulting in increased treatment rates of diabetics. Pune. Management. Devised sales transformation program for Norvasc (Turkey’s best selling anti-hypertensive).S. Istanbul. Istanbul. Rituxan for RA. Herceptin. access solutions. Burtoft Elif Çar colin. Uganda. and product development divisions to modify existing IT solutions for US market needs.. High Honors. Candidate.brown. Ethiopia. Kenya & Kingston. marketing. corporate communication. Tanzania. An opportunity in consulting with exposure to the healthcare sector. CA Associate Program Director.. Planned and coordinated co-promotion business models with Bristol-Myers Squibb and Daiichi Sankyo and led regular executive meetings with country managers of both companies to ensure high level alignment. Alyuta. Jamaica Country Team. Bethlehem. 8 Celgene Corporation. Istanbul. including PR. Brown Alexandra C. A promotional or strategic marketing opportunity focused on oncology/ hematology or rare disease within the biopharmaceutical industry. life-saving commodities and mitigate impending stockouts of HIV drugs. which resulted in 20% unit growth and $22M sales. Chicago.edu Bogazici University. Summit. 2008 An opportunity to work at the intersection of healthcare and technology to improve patient outcomes. 2008 elif. Pioneered the “Creating Perspective” training program to teach sales representatives about the PRC process and evolution of brand messaging. South San Francisco. Jamaica Associate. NJ Hematology Marketing Intern. 2012-2013 Led a 4-person team to develop a cutting-edge marketing analytics tool for Turkey’s largest hospital chain and e-commerce companies. Drug Access Team.edu Lehigh University. brand marketing. 2008-2010 Created complex financial models to quantify the value of Accretive’s revenue cycle initiatives. Turkey Customer Development Manager. medical affairs. Genentech Inc. Sevikar) including regulatory. Chicago.wg15@wharton. M.upenn. Cambridge. program monitoring. Advised portfolio company management teams on strategic planning and business development. audit. beneficiary overlap. proactively sourced and screened investment opportunities. Center for Medicare & Medicaid Innovation.carrillo. process redesign opportunities and training requirements. CA B. 2011-2012 Received Administrator’s Special Citation Award for exceptional work as operational lead and program officer on Pioneer model.A. 2009-2013 Primarily served health insurance clients across multiple projects in technology strategy from operations and process improvement to enterprise-wide system migrations for the Health Insurance Exchanges. NY / Baltimore. improve quality and increase access to care. 9 . Cum Laude. providing the VP of Sales with strategic insights and recommendations related to product adoption. Washington D. Pioneer Accountable Care Organization (ACO) Program Officer. attestation. Delivered a deployment strategy for a newly acquired health care benefit management application. Chang daisy.upenn. implementing 4 initiatives that led to a 53% improvement in total resolution time.chandra. 2011-2013 Healthcare private equity firm with approximately $1B AUM. leveraged buyout. Galen Partners. An operational. Summer 2014 Developed a model to conduct a global data analysis of Google’s technology support team. and support capability gaps.. 2008-2011 Ranked in the top quartile of analyst class. McKinsey & Company. led discussions with executive management teams. MD Healthcare Investment Banking Analyst. and reinsurance policies. or strategic transformation role with provider organizations transitioning to value-based care. CA Consultant. NY Global Equities Summer Associate.C.edu University of California. Business Technology Associate. Mountain View.wg15@wharton. Served as sole Medicare representative to 10 major health systems. 2008 An opportunity to apply my business and technical skill set to strategic and operational roles focused on leveraging technology to lower costs. 2009 alli. MD B.upenn. Negotiated terms of ACO contracts with nine health systems for combined worth of approximately $10B. Google.chang.Daisy J. Supported senior bankers in the procurement and execution of three M&A transactions. Center for Medicare & Medicaid Innovation.C. Co-led online peer learning networks on data analytics.C.wg15@wharton. Industrial Engineering & Operations Research. Conducted fundamental analysis through primary research. New York. Deloitte Consulting. CT Associate. and discounted cash flow analyses. and private investment in public equity. Identified technical infrastructure needs. Los Angeles. and predictive modeling. Analyzed companies using comparable company. eight financings that raised in excess of $1B in equity and debt capital and one valuation assignment.S. financial. Assessed and analyzed investment opportunities across a range of transaction types.B. conducted market scan and fit-gap-analysis for claims product solutions for $1B government project that client is pursuing. Washington. Economics and Psychology. conducted a fit-gap analysis of the client’s customer service team to determine the operational impacts of using a new application.wg15@wharton. Crafted alignment algorithm. Successfully completed five new or follow-on investments and one portfolio company sale. Stamford. Carrillo Alli Chandra Dustin W.edu Johns Hopkins University. New York. In second study. 2012-2013 Launched five payment programs worth $1. risk stratification.. Developed detailed financial models to analyze potential investment opportunities.edu Harvard University. Citadel Investment Group. precedent transaction.5B under aggressive administration deadlines by negotiating technical and press details with senior leadership in HHS and the White House. Summer 2014 In first study. Berkeley. Summer 2014 Initiated coverage or made recommendations on five long/short positions. Baltimore. Special Assistant to the Director. Government.. Analyzed data to identify key drivers of unmet service metrics. growth trends. D. developed framework and identified target companies for $150M HIT purchasing strategy for payer client. Stifel Nicolaus Weisel. CA gTech MBA Intern. leveraged buyout. Washington D. 2010 dustin. analyzing risks and benefits of 4 potential deployment options. including growth equity. An opportunity in private equity with exposure to the healthcare industry. MA A. Additionally. 10 Hospital of the University of Pennsylvania. CIOs. Chemistry. Clark kelly. Deloitte Consulting.upenn. Perelman School of Medicine. Candidate 2015 An entrepreneurial opportunity to address healthcare challenges via technology innovations. Summer 2014 Developed new platform strategy by engaging strategic hardware. Candidate.S.D. Honors. PA B. life sciences. sales. Haverford. 2012-2013 Studied implanted medical devices modified to inhibit pro-inflammatory events. Selected for an oral presentation at the Mid-Atlantic Healthcare Bioinformatics Symposium. among other procedures. business. CA B. Mathematics. and research experiences to a strategic role in medical device innovation. Philadelphia.D.Kelly C. etc. Philadelphia. San Francisco. Franklin Lakes. doubling size of SF HQ. PA B. and hernia repair. 2015 katherine.. Refined system to result in a more sensitive alert. 2009 cyndi. Summer 2013 Sized revenue opportunity for new data analytics business line at $15M in near-term business.upenn. English. McKinsey & Co. Palo Alto. PA Medical Student Researcher. 2012-2013 Conducted interviews and synthesized clinician surveys of a clinical decision support tool for sepsis. life sciences.
[email protected]. 2010-2014 Conducted analyses on risk factors for and outcomes after mandibular distraction osteogenesis. Summer 2014 Developed a business opportunity strategy in medical oncology to identify unmet clinical needs and managed a direct report with full-time dedication to my project. Selected for two presentations at European IR Society Conference. Selected for a presentation at the Scientific Sessions of the American Heart Association.. CA MBA Intern.edu Stanford University. and consumer products industries. Children’s Hospital of Philadelphia. PA M.4B voice recognition company. autologous breast reconstruction...A. . Philadelphia. Published manuscript in the American Journal of Cardiology. operations. 2009 Perelman School of Medicine at the University of Pennsylvania. Interventional Radiology.S.wg15@wharton. Initiated account development in Philadelphia metro region by pitching to 20+ health system CEOs. 2010 M. software. Augmedix. An opportunity to apply my clinical. San Francisco. CMIOs. Designed and implemented hiring processes for 20+ engineering. B. CA Summer Associate 2014 Managed the transformation of clinical trial operations for a global pharmaceutical company. NJ Strategic Innovation Intern. Philadelphia.cheng. Designed and tested analytics prototypes with 35+ external health IT. PA M. PA Graduate Student Researcher.. Phi Beta Kappa. Stanford. Philadelphia. Cardiology. Summa Cum Laude. Managed partnership development with $1. projected to grow to $200M+. Assessed joint venture for integrated delivery network to develop artificial intelligence product with $107B global technology leader. Management Science and Engineering. Published manuscript in Biomaterials.clark. content.edu Haverford College. Becton Dickinson. Practice Fusion.S. plan. CA Business Development Intern. Medical-Surgical Systems. telematics. and services partners. Cheng Cyndi U. San Francisco. Philadelphia. The integration of my science and business backgrounds to make health care more accessible and affordable for patients. software.A. Hospital of the University of Pennsylvania. Chung Katherine A. PA Medical Student Researcher. Modeled post-Health Reform market changes to determine future areas of growth for $8B US health plan.chung..wg15@wharton. 2010 Conducted clinical research on Hereditary Hemorrhagic Telangiectasia and central venous access devices.upenn.edu University of Pennsylvania. Critical Care. Oversaw several workstreams that planned and monitored outsourcing to a contract research organization. and health provider executives. and legal roles. Philadelphia. 2010 Perelman School of Medicine at the University of Pennsylvania. Chemistry. Used deliverables to co-develop a Health Reform Market Offering. CA Consultant 2011-2013 Business Analyst 2009-2011 Strategy consultant for clients in provider. PA Medical Student Researcher. Ascension Health subject matter experts.upenn. Cum Laude. 2012-2013 Directed due diligence processes for prospective hospital acquisitions with Oak Hill professionals. including top-performing investment in Fund IX (Actient Pharmaceuticals). TMT.edu University of Michigan.S. radiation oncology (Vantage Oncology). and presented public and private equity and credit opportunities across healthcare. Ann Arbor.upenn. Led crossfunctional decision-making across engineering. MA B. Castlight Health. IV Nicholas Y. Summer 2014 Sourced. Mount Kellett Capital Management. Barclays Capital / Lehman Brothers. Cambridge. analyzed market
[email protected]@wharton. Identified attractive segments within healthcare sector. NY Analyst. CA Strategy Intern. structural growth/decline. New York. NY Healthcare M&A Analyst.edu Tufts University. Developed mergers and acquisitions template to serve as valuation screening tool. MI B. CA Summer Associate. and grand rounds presentations to inform product strategy and align priorities across teams. Natera./B. and participated in board meetings.B. and financial institutions. New York. conference meetings. diligenced. Mergers & Acquisitions. Led research process. Summer 2014 Developed analytic models and recommended an investment plan for improving women’s health as a part of the strategy for a global health foundation. and transform market-leading companies. Executed five proprietary acquisitions in 24 months to build Actient Pharmaceuticals from management start-up to successful sale ($645M). NY Director of Financial Planning and Analysis. created financial models and assisted portfolio company managers for private equity firm with $3.upenn.crowne. Ascension Health Care Network. NY Analyst. MA A. constructed detailed financial models. business services.edu Harvard University. and largest healthcare equity investment (Sterigenics). Partnered with management team to acquire Cord Blood Registry and worked alongside CEO to evaluate strategic initiatives. Palo Alto. Providence.B.8B in latest fund. Moelis & Company. 2008-2010 Executed financial models to assess M&A transactions and capital structure alternatives. Performed research on third-party administrator industry to identify disruptive growth opportunities. and presented findings directly to CFO. 2009-2010 Merrill Lynch & Co. New York. RI M. 2008-2009 11 . San Carlos. 2009-2013 One of the first employees at Natera.dikan.Michael J. 2010-2012 Performed due diligence. New York. Biomedical Engineering. and investment catalysts to formulate investment theses and assess risk/reward.A. a diagnostics company focused on improving maternal and fetal health through genetic insights. CA Product Manager. and hospital (Ascension Health Care Network) sectors. History. GTCR. Medford. 2008 nicholas. Created multi-hospital leveraged buy-out model to evaluate hospital consolidation opportunity with combined revenues of $1B+. Latin and Finance. 2008 jennifer. 2009 An opportunity to build leading healthcare businesses through investment or management.. Media & Telecom Investment Banking Group. Took insights from the field through sales calls. build.. An opportunity to apply my crossdisciplinary background in engineering and business in a strategic role focused on developing innovative care models and disruptive innovations.S.. with High Distinction. New York.. including analysis of unit economics. marketing. Executed transactions in home health (AccentCare). Dikan michael. and outside consultants. Engineering. Managed workflows across a team of 12 to ensure products and strategy were executed effectively and within executive management and board expectations. Summer 2014 Analyzed 17 adjacent categories to inform buy/build/partner decisionmaking for newly public healthcare technology company.wg15@wharton. 2010-2013 Originated and led $2B of private equity transactions in healthcare sector across 3 platforms.cromwell. Crowne Jennifer A. and sales to develop a suite of prenatal genetic testing products. Cromwell. orchestrated due diligence efforts. New York. IL Associate. McKinsey & Co. NY Summer Associate. GTCR’s first life sciences investment (Cord Blood Registry). 2008 Brown University. San Francisco. An opportunity to identify. Oak Hill Capital Management. NY Private Equity Associate. Chicago. drafted letters of intent. Summer 2014 Led initiative to identify data gaps and design strategic projects for company’s highest-selling oncology drug ($1.edu University of California. including L’Oreal. Summer 2014-Present Implementing system changes via a multi-disciplinary.D. PA M.D.upnn. Los Angeles. Candidate. Direct 12-member team and 23-member International Scientific Advisory Board. increased company profits by 400x in 2 years. Horsham. USNR.drizin. Published research that caused a paradigm shift in the model of pathogenesis. client management. CO Co-Investigator. developed financial models.Dean L.fajgenbaum. MD ENS. China and Japan. 2008 Perelman School of Medicine at the University of Pennsylvania. and Limited Brands in one year.Sc. Corum Inc. Healthcare Group. IPO. Developed comprehensive plan to overcome insurer restrictions to oncology drugs. and supported 15 field sales reps and 30 distribution companies worldwide to establish 15 new Fortune 500 accounts. Summa Cum Laude. M. University of Colorado.A.. NY Associate.4B in 2013). Aurora.. 2006 University of Colorado School of Medicine. 50 key stakeholders spread across 10 business units within Janssen. NY M. 2015 christine. .upenn. Castleman Disease Collaborative Network. assisted in management of portfolio companies of KBL Healthcare Ventures Banc of America Securities. Initiated and oversaw new sales channels and new product indications in North America. Unilever. Developed and identified leverage points along the patient fulfillment process for oncology and immunology strategic imperatives by working with 4 external partners. PA Experience Commercial Leadership Program Intern. reviewed.5M partnership with Janssen Pharmaceuticals to build a first-of-its-kind registry/ natural history study.. PA Co-Founder & Executive Director. CA B. and capital raisings. Developed international business opportunities in 25 countries and planned 50+ product launches through global partnerships.edu Dartmouth College.du. 2010-2012 Spearheaded the company’s strategic plans. KBL Healthcare. Fajgenbaum..S. United States Navy. multi-hospital quality improvement initiative to improve the patient care handoff process. medical
[email protected]. Plainsboro. 2012-2013 Marketing Executive. 2012-Present Launched global initiative to accelerate drug development for Castleman disease. Identified a risk to immuno-oncology field and proposed risk-mitigation solutions. with Distinction. Biochemistry. Marketing Executive.. Taipei Taiwan Sr.wg15@wharton. Philadelphia. New York. PA Adjunct Assistant Professor of Medicine. EU. 2013-Present Appointed faculty member in Division of Hematology/Oncology to conduct clinical research and lead an international study as Principal Investigator. Philadelphia. David C.. NH A. Hanover. 12 Janssen Biotech Inc. prepared company and investor presentations. 2007 Oxford University. Magna Cum Laude. Perelman School of Medicine. Bristol-Myers Squibb. technical investments. Developed in-depth quantitative modeling and transaction experience.upenn. and Zytiga. 2011-Present Medical education funded by the United States Navy Health Professions Scholarship Program (HPSP). University of Pennsylvania. Salutatorian.B. Biotechnology. set global marketing strategy/product positioning and segmentations. CO M. Stelara. Government. 2007 Columbia University. MC. 2014-Present Member. Bethesda. An opportunity in a strategic or consulting role focusing on health care.wg15@wharton. and life sciences sectors for M&A.D. Oxford.. Latin America. New York. DC B. Center for Orphan Disease Research/Therapy. 2013 An opportunity to apply my clinical.. Aurora. will serve as an active duty physician in the United States Navy. NJ Medical Strategy Intern. UK M. Public Health. ultimately leading to an over 20x increase in US sales revenues in 2012. NY Investment Banking Analyst. research and business experiences to accelerate drug development for diseases with significant unmet needs.edu Georgetown University. Philadelphia. communicated with senior management of prospective acquisitions. Upon graduation. New York. 2007-2009 Sourced and evaluated potential transactions. Established $4. david. 2005-2007 Conducted qualitative and quantitative financial analyses for the healthcare services. Trained. Drizin Christine Du dean. Department of Medicine. Human Sciences. Washington. legal processes. 2010 An opportunity to leverage my combined skill set in medicine and management to improve health care delivery and patient outcomes. Summer 2014 Built and piloted specialty pharmacy provider (SPP) performance dashboards for 3 brands: Simponi UC. MA B. Apple Tree Partners. legislative trends.edu Massachusetts Institute of Technology. Summer 2014 Led a project exploring upstream patient education opportunities within hospitals.wg15@wharton. and Medicare / Medicaid policy changes. CO Redwoods Summer Associate. Cambridge. Boston. San Francisco. pension.upenn. 2009-2010 Conducted genetics research to understand the orphan disease of nemaline myopathy. 3) managed crossborder team to develop and deliver training courses to internal and external stakeholders of a public pension fund. Denver. 2) engaged client executives across multiple business units to gain buy-in for an organization change strategy. and HR. Healthcare Investment Banking. Funk zoe. Analyst. Mentored and managed two junior teammates and was recognized as a finalist for officewide “Coach of the Year” award.. Farrell Danika M. DaVita Healthcare Partners. pharmaceuticals. developed presentation materials. and draft S-1 for confidential IPO filing. precedent transactions.B. and claims administration. 2007-2009 Advised healthcare. hospital administration. 2007 M. Convinced 10 separate foundations to transfer funds to a consolidated account to achieve financial and managerial efficiencies.wg15@wharton.. Summer 2014 Provided M&A advisory to specialty pharmaceutical. and DCF.S. 2010-2013. Chicago. 2009 danika.A. 2011-2012 Performed due diligence for private equity clients making healthcare investments. Project examples include cardiac service line and outpatient expansion strategies..Zoe C. Developed marketing materials.funk.. 2011 Strategy consultant for non-profit clients. Co-authored a paper published in a highly regarded genetics journal. 2013 Analyst. Sociology. Sociology. Designed two in-hospital patient education programs that are now being piloted. Boston. Marwood Group. 2012-2013 Senior Associate Consultant. MA Consultant. Negotiated biomed union contracts and directed relevant meetings with site management. CA Summer Associate. San Francisco. DC B. medical device. CA Consultant. Summer 2014 Performed due diligence for two investments that closed in Aug/Sep 2014 as part of the firm’s $1. NJ / New York. An opportunity to advance health care innovation through effective investment and strategic advisory.S. Fry Jennifer L. Physics. 13 . 2010-2011 Associate Consultant. Accounting. training needs.edu Georgetown University. An opportunity to work on a dynamic team within health care services.upenn. conducted diligence.A. IL Senior Associate Consultant. Performed valuation analyses using public comparables. NY Associate. 2007 jennifer. Conducted primary and secondary market research for 100+ projects in numerous healthcare subsectors. 2008-2010 Strategy consultant across sectors.A. Bain & Company. 2008 An opportunity to build successful healthcare businesses through growth equity investment and effective management.edu Stanford University. Developed healthcare IT investment thesis based on extensive literature and field research. Worked with several public health foundations to define their five-year investment strategy at the enterprise and initiative levels. through extensive secondary research and a dozen hospital visits across the country.. Stanford. MA Genetics Researcher. Accenture. NY Summer Associate.farrell. Determined how new kidney patients are educated today on their choices while in the hospital. The Bridgespan Group. New York.S. Biology. and technology firms on organization design. and communication development. Princeton. and process redesign for financial forecasting. and biotechnology companies. merger integration. with a focus on public health. CA B.fry. Washington. and provided process updates to client during a sell-side divesture.67B fund: Series A in the opioid treatment space and Series B in the care coordination space. Select engagements: 1) created a project plan to drive reorganization of Biomedical Technology and Philanthropy business units for a 29-hospital system. Worked with a biotechnology company’s C-suite to perform diligence for a private placement.wg15@wharton. Advised on commercial / government payor reimbursement environments. with healthcare clients in hospital services. with responsibility for both clinical operations and near-term strategy.upenn. Summa Cum Laude. Worked with an entrepreneur-in-residence in the planning stages of a population health management start-up. B. Wells Fargo Securities. Boston Children’s Hospital. 2010-2013 Enabled executives to solve key strategic issues.wg15@wharton. New York. Responsibilities included creating models.goodman.wg15@wharton. Philadelphia. 2009 An opportunity to combine my clinical and business experiences to transform care delivery to improve quality and outcomes. Geoffrion Jeffrey S. Phi Beta Kappa Chemical Engineering. PA Business Associate. CA Performance Excellence Intern. Candidate. Summer 2014 Developed metrics to measure end-oflife quality at KPNC hospice agencies. Economics. NY Senior Associate Consultant. Watertown. An opportunity to apply my strategy experience to an operational role that gives patients access to quality services and/or devices. Summer 2014 Identified. Mergers & Acquisitions Group. The Boston Consulting Group. 2009-2011 Contributed to client acquisition strategy through financial analysis.wg15@wharton. Franklin Lakes. Conducted deep dives in 6 European countries to understand how patients and money flow through each healthcare system in order to best position and communicate value of Medtronic’s solutions portfolio. Cum Laude.E. Partnered with management teams of portfolio companies to create business strategy.A. Summer 2014 Developed growth strategy for Integrated Health Solutions to quintuple revenue by 2018. 2013-2014 Assisted in fundraising activities for AirCare. and delayering ($20M savings) of a consumer goods company. Collaborated with team of investment professionals to close one platform investment. Conducted chart reviews and analyzed variations in cost and outcomes at KPNC medical centers to develop clinical best practices. researched. Kaiser Permanente. and company due diligence. Oakland. five add-on acquisitions. designing decision trees. IL Associate. Evaluated new product launch plans for a med-tech company. NY Analyst. a health IT startup focused on developing a communications and remote monitoring platform to reduce hospital readmissions for patients with CHF. Bank of America Merrill Lynch.edu Princeton University. valuation assessment. An opportunity to help lower middlemarket healthcare services companies develop into industry leaders. and two portfolio company debt financings.Jin Ge Daniel E. NJ Strategy and Development Intern. athenahealth. Chicago. value creation potentials. 2015 daniel. evaluating potential targets. CT B. Projects led to the initiation of a hospital system merger ($7B combined revenue). Princeton.upenn.S.D.geoffrion. Medtronic.. sale of an auto supplier business unit ($500M revenue). Minneapolis.upenn. Magna Cum Laude. 14 Boston Consulting Group. and assessed 200+ prospective healthcare technology partnerships/acquisitions as part of athena’s strategy to build out its inpatient revenue cycle and clinical software solutions. Becton-Dickinson Diagnostics. Modeled costs. Detroit. MA Business Development Intern. and communicating with executives. Identified cost-savings opportunities in the post-merger integration of preclinical and PK/PD units of two biopharmas. . Alpha Omega Alpha. Goodman jin.edu Harvard University. Met with management teams of 35 companies to evaluate their best-of-breed technology-enabled services. 2008 Perelman School of Medicine at the University of Pennsylvania. Economics. resulting in four closed transactions. Summer 2014 Researched innovation thesis to serve the biobanking industry. 2010 jeffrey. New Haven. access financing sources and develop corporate governance as a board observer.ge. Cambridge MA A. Waud Capital Partners. consolidation of 31 equity portfolios ($40B AUM).. and revenue potentials for major players in the sector. MN Corporate Strategy Summer Associate. New York. and consumer services out of the firm’s $463M Fund III. 2008-2010 Developed a brand revitalization plan for a biopharma in the nutritional space. business. 2011-2013 Evaluated and assessed control-oriented growth equity investment opportunities in healthcare.upenn.. market sizing. assess and structure strategic acquisitions.edu Yale University. calculated an economic impact of $400M. NJ B. Philadelphia. MI Associate.B. PA M. developing strategic rationale. Presented analysis and recommendations on how select partnerships may support athena’s effort to address key hospital pain points. AirCare. identified potential customer segments. A Sanofi Company. piloted prototype to hospital executives. MA Analytics Strategy Intern. and created roadmap for late 2014 implementation. 2007 An opportunity to improve patient care through life sciences strategy. New York. and external vendors for multi-billion dollar respiratory portfolio. a chain of primary care clinics acquired in 2012. grow. Cambridge. 2011-2013 Consulting Analyst.upenn.edu Brown University. tech divisions. MA B. 2012-2013 Associate Consultant. and Market Access. and financial clients with life sciences assets. 15 . and created internal sales message. History. NY Private Equity Associate. Amundsen Group – an IMS Health Company. New York. Leerink Swann. and streamlined onboarding process for new hires.. This report was distributed to 200+ clients and presented in firm-wide meeting. leading to a two-thirds reduction in training time. biotechnology. Hahn Miles Hammond seema. industrials. Ranked in top bucket during three out of four review cycles.hahn. 2008-2010 Covered companies across life sciences. and managed care. Organizations and Entrepreneurship. 2010-2012 Advised top 10 pharmaceutical companies on more than 15 projects focused on market access. 2010-2013 Contributed to all aspects of investment process at a healthcare private equity firm with $600M under management. Summer 2013 Identified and analyzed long/short equity investments in healthcare. including Sole M&A advisory on Abbott’s acquisition of Solvay pharma for 4.A. 2010 miles. Built proof-of-concept reporting product. Medical Affairs. Glenhill Capital.wg15@wharton. 2009-2011 Strategy consultant for pharmaceutical. healthcare services. Barclays. led case simulations.edu University of Pennsylvania.6B AUM.. New York. NY Summer Research Analyst. An opportunity to build. New York. PA B. Burlington. An investing role with exposure to health care. Gunda Jonathan D. Participated in 15 transactions across 4 platforms and served on the Board of Primary Care Associates. NY Health Care Investment Banking Analyst.wg15@wharton. Conducted client interviews. marketing strategy. Commercial Operations.Seema A. Commerce. Managed a team of five on a group-wide initiative to improve efficiency and overall experience of consulting group. Summer 2008 Authored 35-page report on value of high-end consumer care products relative to low-end substitutes and impact on sector leaders during recession. MA Senior Associate Consultant. Enhanced Equity Funds. RI B. medical device.. Contributed to several closed transactions. Managed implementation of novel analytics process and led communication across multiple business units. Watertown.upenn. Genzyme. resulting in ~10% revenue increase.gunda. Cambridge. NY Research Associate. and improve health care through strategy or operations. Approach to be leveraged in multiple business units. Chemistry. Experience includes creating a loss of exclusivity strategy for a global pharma client. Built complex modeling tool to assess economic impact of various pricing scenarios on key accounts. Summer 2014 Assessed athena’s analytics strategy for large enterprise clients and reviewed internal and external capabilities to meet anticipated demand. Sanford C.edu Harvard University. NY Consulting Associate. Responsibilities ranged from client management to project management to heavy data analysis and modeling.5B in 2012. Philadelphia. Providence. MA Business Development Intern. Summer 2014 Led initiative to define Genzyme’s investment strategy in Multiple Sclerosis symptoms by prioritizing conditions and conducting a
comprehensive asset scan. Collaborated with R&D.upenn.wg15@wharton. New York. Worked directly with Head of Research to execute and monitor 4 investments during 12-week internship.A. and telecom at a bottomup fundamental long/short equity hedge fund with $1. athenahealth. Bernstein.hammond. Created new hire training program. and pricing/reimbursement issues. 2009 jonathan. which invests in lower middle market healthcare services companies. Analyzed marketing strategy and recommended initiatives focused on patient acquisition.A. attending industry conferences.Elizabeth C. Business Development Manager. Project work included due diligence / strategic transaction support (for manufacturers’ BD/New Products groups and PE/VC investors).A. An opportunity to solve challenging financial. 16 Harris Corporation. MA Equity Research Intern.edu University of Pennsylvania.3% ROS.wg15@wharton. Hansen Andrew D.. 2007-2009 Advised life sciences clients in over 20 consulting engagements in clinical development strategy. Boston.upenn. ultra-rare diseases. Achieved 15. dermatology. Collaborated with clinical. FL B. Biological Basis of Behavior. PA B. M&A strategy. 2012-2013 Analyst. healthcare IT. Healthcare Solutions Team. Led strategic. Computer & Electrical Engineering. technical. Boston. and finance as a project manager to launch dual eligible coordinated care product. Veterans Health Benefit Enrollment Innovation Project. testing and deploying improved software tools. Washington. HQ visits. and discounted cash flow. Santa Ana. commercial opportunity assessments.edu Williams College. Gainesville. contract sales organizations. 2010-2012 Executed 16 new investments and 9 follow-on investments in biotech. Cum Laude.. and healthcare services companies for a venture capital fund with $1B under management. Summer 2014 Provided M&A Advisory for technology companies. IT.upenn. Leerink Partners. Cambridge.wg15@wharton. 2010-2013 Advised a wide range of clients from biotechs to multinational pharmaceutical companies. Focused extensively on the quality of care incentives that providers are facing as a result of healthcare reform and their implications for healthcare manufacturers and investors.edu University of Florida. precedent transactions. Hernandez elizabeth. 2009-2010 Analyst. LBO. Analyzed strategic acquisitions opportunities including redomiciling targets. and private equity and venture capital investors. Williamstown. Summer 2014 Worked directly with the management team of the healthcare services venturebacked company. specialty hospitals.wg15@wharton. and test engineers. Health Essentials LLC. sales force strategy and implementation. Assessed population health software vendors and led RFP process. Served as board observer for two portfolio companies. CA Summer Associate. operations. and expert calls. Performed accretion/ dilution and valuation analysis using public company comparables.S. . regulatory. product life cycle management. Bank of America Merrill Lynch. Technology Investment Banking. market. of Veterans Affairs. medical device companies. cancer. MA Senior Analyst. medical device. Hedin Roberto L. Dept. Summer 2014 Conducted fundamental due diligence on public and private healthcare IT companies through product demonstrations. Clarion Healthcare. software developers. Managed buy-side process and developed management presentations for a leading financial technology firm. by effectively managing an 8 member team of analysts.A. exceeding management’s expectation of 12%. Cum Laude. MA Associate.upenn. 2013 Reduced delays in the enrollment and processing of veterans’ health benefits by designing. operational and strategy problems within health care. novel technologies in emerging markets. hosting company meetings. ophthalmology. Palo Alto.. MA B. developed market and company models.hernandez.hedin. and managed care strategy. 2007 roberto. 2010-2013 Built and fostered my organization’s relationship with the US Coast Guard’s Medical Division and guided that relationship to an $11M contract award to provide our EMR installation and maintenance services. MA Consultant. Engineered the technical specifications and features of a cloud-based electronic health record solution as a member of a multi-disciplinary team of engineers and medical specialists. Economics and Biology 2010 andrew. and financial due diligence efforts. CA MBA Operations Intern. 2013-2014 Associate. and hospital equipment. marketing innovation recommendations. Putnam Investments. and competitive landscape analysis. Invested in private startup companies (Series A – Series D) focused on healthcare IT. LLC. Fidelity Biosciences. 2007 A direct investing opportunity with exposure to the healthcare sector. Philadelphia. An opportunity to operate and invest in innovative health care companies through venture capital or private equity. Boston. DC Project Manager.hansen. New York. An opportunity to build leading health care companies using my expertise in medicine and business. establishing a delivery radius across 68 zip codes. Durham. CA B. DC Senior Consultant. strategic capability assessment and design. Warren. Developed materials for and participated in Scientific Advisory Committee meeting regarding the acquisition. Buenos Aires. established strategic partnerships. Jones Ford Kerr Michael J. Phi Beta Kappa. Constructed long-range plan for Organ & Tissue Therapeutics division. Completed the Medtronic Emerging Leader Program (participants are chosen through a rigorous selection process that identifies high performing employees). Awarded admission into 3 competitive startup accelerator programs and won the Wharton Venture Award. Biomechanical Engineering. and Neurosurgical Post-Operative Monitoring and Complications.S.wg15@wharton. and launched the company. Atlanta. a wholly owned subsidiary of Celgene Corporation.D. NJ Strategy Intern. PA M. detailing competitors’ products. Philosophy. TN Senior Product Development Engineer. companion diagnostics. Designed/implemented supplier operating model in 2 stores in 2 months. Summa Cum Laude.wg15@wharton. Led cross-functional team on strategic projects to develop custom implants in order to improve the lives of patients and convince competitive surgeons to adopt Medtronic products. 2010 Perelman School of Medicine at the University of Pennsylvania. PA Co-Founder and CFO.E. Authored three textbook chapters on pediatric neurosurgical topics published in Pediatric Cancer. 2007 michael. and completion of process validations on new equipment and fixtures. and co-led the 6-month restructuring of a private microfinance firm. LifebankUSA.000 in seed funding. Candidate. Celgene Corporation. Summer 2014 Managed materials workstream on healthcare project that involved creating and monitoring a war room. Internal Consultant. 2011-2012 Strategy consultant for pharmaceutical.edu Stanford University. Biomedical Engineering. and commercial opportunity assessments in the digital/mobile health space. Medtronic Spinal & Biologics. developed/implemented client training programs to teach foundational business skills.S.S. Fitly. Assessed next-generation opportunities for placental-derived regenerative medicine platform. Argentina Loan Officer.jones. raised $210. biotechnology.kerr. companion diagnostics strategy. 2013 Consultant. CO B. PA Research Fellow. Spine Surgery Basics. Stanford.. Philadelphia.wg15@wharton. Philadelphia. pricing. 17 . Kramarz luis.. and payer clients with project experience in strategic launch planning. Summer 2014 Worked in a strategy role within Celgene Cellular Therapeutics (CCT). and implementing process improvements in order to assist the client in meeting critical product delivery dates. McKinsey & Company. 2008 ford.upenn. Alpha Omega Alpha.kramarz. assessing technology’s efficacy and indications. Implemented process improvements through the execution and timely closure of nonconformance reports. Cum Laude. 2015 An opportunity to solve challenging problems in the health care industry. Summer 2013 Performed clinical due diligence for $35M acquisition target. Irvine. Memphis. NY Intern. An opportunity requiring entrepreneurial and strategic thinking within the context of mobile health. Philadelphia. Colorado Springs. 2008-2010 Managed team of engineers and technicians that provided focused quality support on micro catheters production lines.Luis M. NC B. HealthpointCapital. Washington.A.. Summer 2011 Conducted clinical research in the Department of Neurosurgery resulting in poster presentation at annual American Association of Neurological Surgeons meeting and publication in Neurosurgery. Children’s Hospital of Philadelphia.edu Duke University. and market positions. tracking key process metrics. Entre Todos (Microfinance Company). Analyzed specific growth strategy for CCT’s umbilical cord blood bank. 2010-2013 Designed and developed innovative instruments to facilitate the insertion of spinal implants by collecting and analyzing feedback from surgeons.upenn. CA Quality Engineering Team Lead. Summer 2013-Present Developed launch strategy.edu Colorado College. 2009-2010 Worked as a loan officer with a portfolio of 70+ clients. GA Summer Associate. 2006 M. Covidien Neurovascular. maintenance and analysis of statistical process control charts. post-merger integration.. Mechanical Engineering. or other disruptive forces with potential to make a significant impact on the health care industry. Booz & Company. pipeline asset evaluation.upenn. Analyzed the competitive landscape. PA Research Fellow. Multiple publications published in peer-reviewed journals. lindsay. 2010 An opportunity to apply clinical and business knowledge to advance the quality of care patients receive. Liao jonathan. Philadelphia.Lindsay E. Executed a segmentation of clients and identified opportunities to reprioritize sales. Presented at national meetings. MA Strategy and Business Development Associate. 2008 An opportunity in strategy and business development at a growth stage healthcare services or technology company. and physician messaging strategies for pre-launch and in-line products. Clinical Transformation. Created models to project the market size and value of additional physician members. 2013 Consultant. Experienced in surgical critical care and cardiovascular surgical critical care. Business Planning & Development for Parks & Resorts. Brain and Cognitive Sciences. Center for Surgery and Health Economics. 18 Jonathan M.lanznar. Cedars-Sinai Health System. and consumer segmentation for annual business line reviews with more than 20 finance and operations leaders. Department of Surgery. PA Resident in General Surgery. presented to executive team and insights incorporated into fundraising strategy. Literature.Y. Summer 2014 Developed the go-to-market strategy for a new product targeting high-value medical technology companies and managed the initial sales team rollout. Hospital of the University of Pennsylvania. bariatric. minimally invasive. The Walt Disney Company. Developed various product positioning. Psychology. Programs ranged from product launches to mergers and acquisitions.B. Cambridge. MA S. 2008-2010 Conducted financial modeling and due diligence research on potential acquisition targets in the travel and leisure sector. daily patient care decision-making. and health services research.upenn.upenn.000 to $2M. Designed and launched a global Center of Excellence in access and reimbursement for a $15B biotechnology firm. Waltham. Los Angeles. 2010-Present Responsible for all aspects of pre-. Currently at the post-graduate year 5 level.D. and general abdominal surgery. Responsible for leading the inpatient care team.S. Summer 2014 Led 15-member cross-disciplinary task force in developing the strategy and tactical roadmap for managing financial and clinical risk in new payer contracts. Responsibilities include operating. CA Financial Analyst.wg15@wharton. Hospital of the University of Pennsylvania. Phi Beta Kappa christina..and post-operative care.. 2008-2011 Managed brand development programs with cross-functional teams for 15+ clients across the healthcare industry. CA Senior Consultant. Received a research grant from the Society of American Gastrointestinal and Endoscopic Surgeons.edu Emory University. segmentation. NY Senior Consultant. B. biotechnology. CA MBA Intern. Example projects include: creating the integration strategy for the merger of two medical device companies.wg15@wharton. 2011-2013 Consultant. and experience of patient care at an integrated health system.kuo.upenn.A. Biology. July 2013-Present Performed outcomes research. Atlanta. 2010-2011 Advised top 10 pharmaceutical. Lanznar Christina S. colorectal. trauma. New York. profitability benchmarking analysis. primarily focused on endocrine surgery. Cambridge. marketing and partnership targets.S. Life Sciences. An opportunity to improve the quality. Quantia Inc. including multiple junior residents and mid-level providers. 2006 Northwestern University Feinberg School of Medicine. and communicating with patients/ families. Philadelphia. GA B.edu Massachusetts Institute of Technology. efficiency.. Experienced in diagnosis and treatment of vascular. Designed pilot program for e-visits and presented recommendations to Medical and Clinical Directors to gain operational buy-in. 2008. Life Sciences. Kuo. intra. Led market sizing. Los Angeles. MA B.edu Massachusetts Institute of Technology. IL M.D.. Department of Surgery. and consolidating a headache market segmentation to identify core prime prospects to achieve an $18M yearly growth target. Responsible for medical student teaching integrated into all aspects of clinical surgery. Monitor Group. 2011-2013 Associate Consultant. and medical device clients on marketing and organizational strategies. thoracic..wg15@wharton. M. Burbank. coordinating the rollout of a new strategy for a diagnostic services company while growing the account from $600. InterbrandHealth. endocrine and oncologic.liao. Chicago. . Magna Cum Laude...edu Princeton University. CA @WalmartLabs Mobile Strategy Intern. NY Consultant.. infectious disease. Summer 2014 As a member of the launch strategy team for an asset in Phase III. 2) enabling international growth initiatives by reprioritizing budget allocations and discretionary spend for a medical device company 3) analyzing consumer purchase habits and marketing effectiveness for an ecommerce retailer. leading to 2 new investment theses.B. Areas of project focus include oncology. financed. hematology. Turned around hospital from perennial operating losses to highest net patient revenues and earnings in its 60-year history. Patricia J. MA New Product Commercialization Intern. Project responsibilities included creation of detailed forecast models.. Chicago. Summer 2014 Engaged in all aspects of healthcare services investment processes including due diligence.lipkind. Oversaw operations and growth of health care provider holding company. Magna Cum Laude. Assessed iPad app performance across the business portfolio to identify strengths and pain-points. 2009-2013 Managed over 400 employees. and management services to physician practices and hospitals.wg15@wharton. Rahway. 19 .D. 2008-2012 Led strategic consulting projects for six top 15 pharmaceutical companies. 2010-2013 Provided strategic and managerial guidance for companies across both the health care and retail industries. and financing. Associate. design of payer contract terms. Philadelphia. structuring pharmaceutical distribution contracts. Summer 2014 Evaluated mobile trends and features for Walmart to prioritize going forward. Conducted research across competitor mobile grocery apps to understand desired functionality in preparation for the Walmart To Go (grocery delivery) app launch. An opportunity to create value for healthcare businesses through private equity investing or strategy role. IL Summer Associate. Management & Operations Management. nutrition or biopharmaceutical sectors through a direct investing. Organized network affiliations with multiple physician practices. conducted primary research. NJ A. modeling.wg15@wharton.. compliance. Advised investment committee on healthcare services trends and sector opportunities. decreased liabilities 45%. trained. J. Hosted business development meetings with entrepreneurs interested in partnering with Walmart in the mobile technology space. IL B. Political Science. Senior Associate. with project work focused on customer and market insights. Liu david. Evanston. doubled hospital assets. 2010 An opportunity to grow a company in the wellness. 2006 Boston University School of Law. Consultant. 2007 ethan. Princeton. An opportunity to pursue strategy and marketing to impact consumer health and nutrition within the retail sector.wg15@wharton. Putnam Associates. Burlington. structured. 2011-2014 Provide legal.upenn. MA Senior Consultant. 2009 patricia. NJ Associate Chemist. Sample projects: 1) performing a deep-dive on stakeholder influencers to improve provider targeting and segmentation for a pharmaceutical company. Cressey and Co.. neuromuscular condition. patient and physician strategic segmentation for marketing activities. increased operating revenues 154%. 2012-2013 Analyst. and recommendations on clinical development plans. and executed acquisition of 2 community hospitals. MA J. New York. and three top 10 biotechnology companies. Michigan Rural Healthcare Preservation Holding Co. and oversaw 30+ junior team members (~ 4-5 per project). recommendation on tactics for engagement with patient advocacy. strategy or operations role. developed. led a project to develop a strategy and identify tactics to improve the efficiency of diagnosis of a rare. Cambridge. As a manager. Deloitte Consulting. Worked with cross-functional internal partners. Lipkind.upenn. Chicago. Complete Healthcare Management..light.edu Northwestern University. sourced and managed external consultants. IL and MI CEO. Director. Merck & Co. Slavic Studies.D. 4) developing a predictive scorecard to enable store expansion for a global retailer. and health IT. 2007-2008 Designed and synthesized over 100 novel small-molecule drug candidates based on structure-activity data and spectroscopic analyses.liu. responsible for all investment and corporate development decisions. d/b/a Michigan Clinic.David E. Boston. PA B. Biogen Idec. Chemistry. neurology. San Bruno. and a medical school. sample transaction: formed multi-specialty group by merging neurosurgery and interventional radiology physician practices and launched stand-alone diagnostic medical imaging center to capture revenues from new group’s referrals.edu University of Pennsylvania.A. and presented recommendations directly to division Vice President. a research institute. Contributed to patents for two drug candidate scaffolds. Walmart eCommerce. Light Ethan I.S. IL Principal. Sourced.upenn. Chicago. organized annual fundraisers.edu Duke University.mackay. Bain & Company. Beijing. Beijing. and received high remarks. and hand surgery. cosmetic surgery. Awarded “Best Project Execution”. built and ran online presence. Established strategic partnership with industry key opinion leaders and enhanced clients’ clinical expertise with physician education programs. Neuroscience and Psychology.edu Peking University. McKinsey & Company. Director 2009-Present Friends of NOAH USA.. 2005 duncan. USA. Novosibirsk. trauma
[email protected]. including general reconstructive surgery. and psychosocial support to the extended family network of children in South Africa who have been orphaned by AIDS. IL Associate Consultant. craniofacial surgery. The Boston Consulting Group.wg15@wharton. assessed and implemented executive culture and communication improvements.A.upenn. Durham. Candidate 2015 An opportunity in management consulting or international business development focused in healthcare. assessed and recommended M&A targets. “Early Bird”. (Nurturing Orphans of AIDS for Humanity).Braun Medical. Philadelphia.upenn. 2007-2009 As a strategy consultant. Beijing. Ernst & Young.000 and care for over 250 children. Russia.. Co-ran the organization. To date.edu Novosibirsk State University of Economics and Management. 2009-2010 Managed sales at the largest cardiovascular hospital key account in China. Moscow. Developed and implemented plan for a pre-acquisition debt restructuring. Pittsburgh. we have raised over $120. 2014 Co-developed subsidiary role classification system and management guidelines for the governance of overseas subsidiaries for a leading global ICT solutions provider head quartered in China. 2011-2013 Led a team of analysts to perform analysis of economic and operational performance of the company with a $7B revenue for the needs of investors and management. Awarded as a manager of the best audit project in 2010. Was elected by the company’s senior management to the board of experts. Friends of NOAH. Shanghai. NC B. Cum Laude. B. Russia Head of Financial and Economic Analysis Department. Built valuation model for a company’s acquisition. educational.D. Summer 2014 Worked with a client team to run analysis and develop opportunities to increase revenues. Summer 2014 Acting intern on plastic surgery service. Hershey. Designed audit procedures that were included in the monthly emails distribution as best practices examples. treating patients. History. An opportunity in pharma/biotech strategy analysis or health care consulting.S. Designed key account management model to optimize resource allocation and created performance improvement initiatives to enhance sales team productivity. 2010-2011 Developed sales strategies to increase market penetration. PA M. Moscow. 2005-2011 Led a team of auditors focused on serving pharmaceutical companies and healthcare providers. 2007 Perelman School of Medicine at the University of Pennsylvania. is a grassroots nonprofit designed to help communities raise their orphaned children by providing physical. Chicago. University of Pittsburgh Medical Center. China Sales Management Trainee.upenn. 2012 Senior Sales. 20 TMK.. “Key Account Management Champion”. presented findings to the head of Investment Management Department. Russia Associate. researched and assessed our practices and outcomes.A.Wei (Lluvy) Liu Sofya Lyashko Duncan Mackay wei.wg15@wharton. Built financial models. Conducted benchmark study on foreign subsidiary management of 4 global technology conglomerates. China Summer Consultant. and “Excellent New Employee”. Received full score in annual performance evaluation with fast-track promotion and awarded “Best Sales”. doubling sales revenue and market share of previous year. B. . Philadelphia. assisting in surgery across the spectrum of the plastic surgical field. An opportunity to integrate my medical and business expertise to improve design of health care delivery systems.liu. Achieved 25% reduction in the project time and 60% growth in the project’s profitability. developed research tools. structured and performed analyses that drove impactful recommendations for Fortune 500 clients. PA. 2009 sofya. Active in clinical and basic science research. breast reconstruction. PA Sub-Internships in Plastic Surgery. China Key Account Supervisor. Russia Manager. Johnson & Johnson Medical. Moscow. PA Co-founder. China B. University of Pennsylvania Health System. Summer 2014 Designed and executed an NPV analysis to assess commercial value of an internal asset and biomarker strategy in a large lymphoma indication. Biogen Idec. Italy B. Developed segmentation for Zalora’s 200.A. Manderscheid kristen. Durham. to inform indication prioritization and global commercial forecast.A. including review of treatment process and competitive landscape.wg15@wharton. Major projects were: future-state design of global quality control processes within clinical trial data management.edu Duke University.manderscheid.. 2008 Kristen E. 2012-2013 Analyst. launch planning. commercial drugs. 2010 Carlo Martelossi carlo. Milan. Summit. MA Pricing & Reimbursement Strategy MBA Intern. Summer 2014 Designed and implemented new processes for promotional campaign development and customer relationship management teams. 2008-2010 Sales and marketing strategy consultant for pharmaceutical.S.S. and medical device companies. Deloitte Consulting. MA Consultant.S. Indonesia Marketing Intern. Italy Associate. Boston. 2011 An opportunity in strategy or business development at a biotech or pharmaceutical company.S. 21 .S. creating new roles. 2012-2013 Associate Consultant. Zalora.upenn. CT B. process design. Milan. analytical model development. Designed and analyzed quantitative research instruments to inform commercial strategy. NJ Global Marketing Intern. France. Fall 2010 Managed coverage activities on clients in the consumer.. Performed competitive analysis and quantitative assessment of the Italian Generics market in strategic due diligence on pharmaceutical company for top private equity firm. brand planning tool to effectively manage marketing spend for client’s top 25 U.martelossi. ZS Associates. 2011-2013 Identified and launched strategic pricing initiatives in Germany. Created global messaging platform based on results of a randomized clinical trial and collaborated with US and global marketing leadership to validate and deliver messages. The Boston Consulting Group. Jakarta. Finance. Analyzed development opportunity of a pipeline asset in a niche lymphoma indication not currently addressed. Celgene Corporation. New Haven. Cambridge. Italy Investment Banking Intern. to inform U. Responsibilities included strategic advisement. and creation of business analytics to track effectiveness of a global data compliance project across 57 countries and 5 third-party vendors. and introducing new incentive schemes. and project management. and Spain for major American medical device manufacturer as part of the redefinition of the go-to-market model leading to $25M bottom-line
[email protected]. An opportunity to make an impact and create value through operational improvements. industrial and healthcare sectors.edu Yale University.B.Amit A. An opportunity to develop and refine global pricing and market access strategies for select pipeline assets. 2010-2012 Strategy and operations consultant focused primarily on pharmaceutical clients. Milan. Boston. Psychology / Behavioral Neuroscience. development of a U.upenn. Worked closely with clinical team to design clinical trial scenarios to support development of asset. and recommendation of how to optimize value of the asset. Defined new customer segmentation and targeting strategy for top European corporate and investment bank based on opportunities for crossselling of high-value-added products resulting in $50M increase in revenues. Deutsche Bank. Magna Cum Laude.000 customers in Indonesia based on identified main drivers of purchasing behavior and launched pilot to evaluate the effectiveness of newsletters tailored to customer preferences. Supported the P&RS group by providing pricing estimates for an early-stage pipeline asset across three targeted indications. Moderated qualitative interviews with physicians (across many specialties) and patients. M. NC B. retail. Managed teams of associates in conducting qualitative and quantitative market strategy engagements. and Germany. Summer 2014 Led a project examining the financial and strategic impact of federally mandated 340B drug discounts on a pipeline asset. MA Consultant..edu Bocconi University.S. to understand value drivers and pricing potential for pipeline drug.wg15@wharton. Mahadevia amit.. Economics. clarifying responsibilities.upenn. Helped manage an external vendor conducting primary payer research in U. biotech. 2010-2012 Business Associate. including ROI analysis of palliative care and a toolkit for improving project management skills. 2008 An opportunity to apply my medical and business experience to improve patient quality of care. RI Senior Analyst. participating in the Institutional Review Board process. Summer 2014 Led teams in the execution of multiple M&A processes.D. and use of advanced practice providers. MA B. Aetna Accountable Care Solutions. DC Senior Analyst.phillips.to 90-day supply of select maintenance medications.perlmutter. Cum Laude. Candidate. Washington. spinal cord injury. Cambridge. 2005 University of Pennsylvania School of Medicine. ICU management.. Molecular Cellular and Developmental Biology. Department of Orthopaedic Surgery. and pharmaceutical industries.S. 2010-2011 Completed four best-practice research studies and several web conferences for a client base of 400+ senior hospital executives. 2011-2014 Critically examined precipitating factors for unplanned admission to the intensive care unit following arthroplasty. 2009-2010 Investigated traumatic brain injury. and partnership strategies for a variety of corporations across the pharmacy. Louis. growth. TN Associate. Spearheaded due diligence process in preparation for first published study. Leveraged this capability to retain Walgreens patients during the Walgreens-Express Scripts dispute.wg15@wharton. phantom limb pain and other sequela of amputation.. Summer 2008 Treated multiple amputee patients with experimental mirror therapy designed to reduce phantom limb pain. Developed tools to help clients implement best practice strategies. University of Pennsylvania Health System.upenn. or business development to improve value in health care delivery. College Honors.mcauliffe. the creation of marketing materials and the underwriting of $140M in capital raises for middlemarket health care services businesses. physician leadership development. Nashville.A. and assisting with the execution of protocols. Developed business case and new product concept for comprehensive at-home care solution to help providers lower the total cost of care. 2011-2013 Designed and implemented a new chain-wide service guiding patients and doctors through the process of switching from a 30. Participated in several original research projects by writing research protocols. insurance. New Haven. An opportunity in strategy. Phillips caitlin. 2015 lisa. Physical Medicine and Rehabilitation Service. Monitor Company Group. A health care finance role in banking. CT B. .. St. Philadelphia.wg15@wharton. leveraging my prior operational and strategic experience. Washington. MO B. simultaneously laying groundwork for multiple subsequent studies. 2009 gordon. PA M.wg15@wharton. The Advisory Board Company.upenn. with ultimate goal of maximizing patient safety and clinical quality in joint replacement surgery. DC Research Assistant. Walter Reed Army Medical Center. Williamstown. Washington. Philadelphia. Raymond James.Caitlin L.A. primarily in the behavioral health and hospice industries. DC Clinical Research Assistant.upenn. increasing prescription drug adherence by 15% for converted patients and converting over 1M patients in first 12 months of program operation. 22 CVS Caremark. CT Product Strategy/Market Intelligence Intern.edu Yale University. Analyzed primary and secondary research into actionable strategies for hospital executives on topics including clinical quality performance.edu Williams College. Perlmutter Gordon I. McAuliffe Lisa E. physician engagement and contracting. operations. 2012-2013 Research Analyst. PA Research Assistant. private equity or business development. Woonsocket. Center for Neuroscience and Regenerative Medicine.edu Washington University. Walter Reed Army Medical Center. Math & Economics. 2008-2011 Led teams in the creation of pricing. Hartford. Created due diligence model to evaluate one of Aetna’s business strategies and the viability of a new solution in three markets. MA Senior Consultant. Summer 2014 Member of team forging innovative partnerships and insurance models with providers. Psychology. Examples include the creation of an econometricallyderived Medicare prescription drug plan pricing strategy for a national health insurer and prioritizing the development of pharmacogenomics revenue streams for a leading pharmacy benefits manager. Molecular & Cellular Biology. Proposed solutions to address the short and long term implications of healthcare reform.upenn. and managed cross-functional teams of experts in law. LLC (dba Kool Smiles). market. Summer 2014 Assisted deal teams in four licensing. Atlanta. Led reimbursement. 2010-2012 Led team of 7 during pilot and expansion of orthodontic program. New York. Originated 11 Letters of Intent representing $1B of Summit Partners’ capital. synthesized findings to develop orphan disease business strategy for Fortune 50 pharmaceutical company. Berkeley. 2007-2009 Originated and executed healthcare private equity investments. Ritz visali.edu Georgia Institute of Technology.. Frankel Group LLC. CA B. 2008-2010 Consulted self-funded employers (ranging from 2. and presented them to the portfolio managers. and wellness as well as vendor account managers and implementation leads.000 to 150. A direct investing opportunity with exposure to the healthcare sector. 2013 Associate. 2010-2011 Provided strategic recommendations to guide pharmaceutical and biotech companies’ global R&D investments. and administration issues. Created pricing. CA Business Development Intern.000 of revenues to 14 offices representing $2M of revenues in 6 months. 23 .000 employees) in solving major healthcare service. reference checks and built financial models for equity investment ideas in various industries.upenn. CA Product Marketing Intern. CA Associate. and supporting negotiations in Immunology and Infectious Diseases spaces. acquisition. Corporate Marketing. and VP of Sales to develop a multi-year business plan strategy: outlined sales process and target market. Led the West Coast offices in Data Warehouse & Healthcare Analytics sales and implementations. and established strategic partnerships with wellness companies and benefits consultants to leverage synergies among product and service offerings.wg15@wharton. San Francisco. 2010-2011 Analyst. Atlanta. Highest Honors. analyzed market research and secondary data to develop $2B revenue model for immune-based renal diseases. wrote investment memorandums. 2011-2013 Senior Analyst. CA Senior Associate. Genentech Inc. drafting term sheets. Omada Health. Summit Partners.ritz. Ramanathan Emily T. and modeled deal return scenarios. An opportunity to build and grow a health technology company.Visali V. sell. Spring Semester 2014 Worked 10-20 hours per week during the spring semester.edu University of California.reid.B. cost. Atlanta. CA Business Development Consultant. After receiving approval. Mercer. Tiger Global Management. Created investor presentation for a development stage biotech and collaborated with CEO to determine differentiating properties of novel drug and appropriate level of clinical data disclosure for a non-scientific audience. NY Senior Associate. Evaluated potential partnerships and deal structures to enable microbiome research and presented recommendations to senior leadership. Conducted primary research. Cambridge. and capital spending strategies and presented recommendations to executive management team.. and payers. 2011-2012 Analyst. GA Business Development Manager. New York. GA Summer Associate. hold. pharmacy. Developed 9-year renal disease business strategy totaling $8B in revenue for Fortune 50 pharmaceutical company. Cornerstone Investment Partners. 2012-2013 Senior Financial Analyst. roll-out. Castlight Health.wg15@wharton. Honors.edu Harvard University.ramanathan. MA A. NY Analyst Intern. and Customer Success. grew program from pilot in 2 offices representing $200. 2008 matthew. and financial due diligence efforts. San Francisco. Cum Laude. Conducted primary interviews.wg15@wharton. regulatory. 2007 An opportunity to identify and build successful life sciences companies through a business development or investing role. VP of Marketing.S. Led team in conducting 150 primary interviews targeting physicians.upenn. and collaboration deals by conducting scientific. Reid Matthew B. Summer 2014 Partnered with the Product and Sales teams to develop collateral for recent and upcoming product releases. Summer 2014 Performed fundamental analysis of domestic equities for $9B fund. 2010 emily. and developed pricing strategy. GA B.. Palo Alto. Assessed market competition and product positioning. Summer 2013 Collaborated with Co-Founders. San Francisco.. Management. 2012-2013 Associate. Public Health.A. patients. Drove the creation and operationalization of customer case studies in coordination with Sales Senior Leadership. legal and financial due diligence. Constructed buy. NCDR. and pass recommendations for 30+ stocks. South San Francisco. UK Summer Associate. Research led to a $50M equity long position. Biochemical Engineering & Biotechnology. Italy. Boston. Chemistry and Psychology. Morgan’s technology.P.Charlie A. January 2009. India. Rupert Ankit Saxena charles. Boston. NC Global Value Chain Manager-Influenza Portfolio. 2007 ankit. Performance Technologies.S.robinson.wg15@wharton.. 2009-2011 Led planning. London. Summer 2014 Developed product concept to support accountable care organizations.wg15@wharton. and chronic disease management.K.P. Washington. and Specialty Care Services. supported development of external partnerships designed to enhance accountable care organizations. and insurance programs. PA BA.. Raleigh. Managed cross-functional projects in supply chain. New York. 2007-2009 Explored success and failure of venture capital-funded healthcare companies. 2007-2009 Performed credit reviews for J. NY Analyst. The Advisory Board Company. Robinson Alexander V. and implementation. manufacturing. Philadelphia. NH A. partnerships. Aetna Accountable Care Solutions.A. An opportunity to improve the interactions among various stakeholders within the healthcare value chain. including recommendations for technology utilization. Analyst.edu Indian Institute of Technology (IIT). 2013-2014 Developed two-part marketing strategy: 1) Outbound marketing initiatives such as vendor shows that resulted in 30 active customers within first 8 months of operations. Created detailed operating models and analyzed capital structure alternatives including rights offerings. and provided execution support for program improvements. NY Associate. Wharton Center for Health Management & Economics. 2011-2013 Worked on a team that launched a new business intelligence tool designed to empower a data-driven approach to physician network development. Philadelphia. 2) Inbound marketing initiatives via SEO and customer analytics (impressions. SQZ Biotechnologies. media. . & Senior Analyst. Investigated Monster Beverage Corp’s convenience store sales strategy to model growth opportunity. Summa Cum Laude. data connectivity. New York. published article in Health Affairs. analyzed large data sets. J. 2009 An opportunity to improve healthcare delivery through innovations in care management. and finance across U. 2009-2011 Collaborated with management teams of automotive and insurance companies to create financial models and business plans for corporate restructurings. presenting recommendations to the Investment Committee. execution and issue management for portfolio comprising 6 influenza vaccine products accounting for 25% of revenue for the division. Wrote a weekly update for report to CEO on restructuring situations. India Dual Degree Bachelor and Master of Technology. The Blackstone Group. TX Dedicated Advisor. that resulted in 2x growth in traffic in 2 months. 24 King Street Capital Management. click-through rate.B.edu University of Pennsylvania. College of Arts & Sciences. informatics.. NY Analyst. English. Associate. 2014 Generated investment ideas in the paper and packaging and European airlines spaces. obesity. 2011-2013 Worked with fund Partners on distressed credit opportunities and long-short equity positions. MA Product Strategy Intern. Research & Insights. U. Developed hypothesis and analysis framework for savings in Durable Medical Equipment. Morgan. New Delhi. Taconic Capital Advisors. patient engagement. DC / Austin.wg15@wharton. Formulated strategies to negotiate with stakeholders and regulators. Met with management teams and consulted industry experts to discover business risks and opportunities. developed work plans.upenn.edu Dartmouth College. Developed recovery model to determine value of unsecured claims at various entities in the American Airlines capital structure. New York. used pro-forma modeling to inform technology and infrastructure investments. and conversions). MA Marketing Head. Summer 2014 Analyzed network strategy at a major health insurer to achieve 15% medical cost saving for launch of a $5B consumerdirected business. Cum Laude. PA Researcher. and telecommunications loan portfolio. 2008-2011 Developed hospital strategies for clinical technology adoption and specialty program development.saxena. led a team specializing in minimally invasive surgery. NY Associate. An opportunity with a hedge fund investing across the capital structure.upenn. 2008 alexander. Novartis Vaccines & Diagnostics. engineering. Assessed widespread media reports regarding health hazards associated with energy drinks. New York.upenn. and Germany.rupert. Hanover. Strategy& (formerly Booz & Company). 2011-2013 Global Technical Leadership Program Associate. performing valuation analyses. medical devices and diagnostics industries. London. CA Associate Director. UK Senior house physician (resident) 2009-2011 Prioritized. NY Associate Consultant. merger consequences. encompassing multiple follow-on projects. Managed client relationships and internal project teams as large as 5-6 employees globally and officially mentored 3 junior employees.S. UK B. Business Administration (Finance).9B biotechnology company.Sc.schulz. 2005 bedir. PA B. Delivered clinical results while working to tight deadlines in a highly pressured environment.wg15@wharton.. integral in growth to 7 employees and ~10% of practice’s revenues within first year. arranged debt financing. PA B. Altaris Capital Partners. A role blending strategy and operations for a provider focused healthcare IT solution. Valence Health. private equity investments. and treated inpatient admissions across a variety of specialties in internal medicine and general surgery.upenn. Performed financial analyses including DCF and trading comparables for an $80M private placement round for an innovative diagnostics company.sinensky. 2008 An opportunity with a private equity fund investing in the healthcare sector.. Closed four deals including three M&A transactions and one equity offering. M.edu University of Pennsylvania. NY / San Francisco. Closed four deals including two LBOs. Supported upcoming product user experience overhaul. Adam R.wg15@wharton. managed diligence work flow. University Honors. Led multiple long-term client relationships. conducting due diligence on over 30 potential acquisition targets for a $1. 2009 Imperial College London. Monitored existing portfolio companies by attending board meetings. Summer 2014 Advised clients in the biotechnology. Worked with R&D team to build models to identify target biomarkers. diagnosed. CA & London. J. Chicago. Bedir W. Teladoc. Wrote requirements documentation for development of 5 new product features leveraging Agile process. UK Associate to the Chief Medical Officer. Magna Cum Laude. San Diego. Led the development of a clinical marketing campaign for the company’s first appearance at the ASCO. New York. Sinensky adam. 2007 An opportunity to help build an innovative health care company through a business development role. Navigant Consulting Life Sciences Advisory Services. IL Product Definition Intern. Shather. 2011-2013 Assessed and executed new healthcare acquisition opportunities. and reviewing strategic opportunities with management. Schulz matthew. NY Analyst. Leerink Partners / Merrill Lynch. including development of user personas and interface redesign. CA Summer Associate in Health Care Investment Banking. 2013 Managing Consultant. New York. one add-on. 2012-2013 Part of a clinical team tasked with identifying target areas for product development. Performed sum of the parts DCF valuation as part of a defense strategy for an $8. ZS Associates. Led the creation of a buy-side M&A ideas pitchbook.P.wg15@wharton. Pittsburgh. Summer 2014 Established standard operating procedures for demonstrating suite of health provider IT products to customers. equity-linked and debt financing alternatives. Sourced potential investors and negotiated term sheets for Series F fundraise. National Health Service. San Francisco. 2007-2009 Associate. leading to the creation of 3 oncology panel tests used by a number of academic medical centers. London.S. CT MBA Associate. Leeds. and IPO scenarios for companies across the healthcare industry. Assisted in fundraising process for Altaris’ third fund.edu University of Leeds Medical School. New York. 2010-2013 Senior Consultant. and one exit.Matthew L. Drafted transaction documents. Joined a group of over 20 investment bankers from Merrill Lynch who assumed leadership of the investment banking platform at Leerink Partners. 2008-2011 Analyzed equity.edu Carnegie Mellon University. Greenwich.E. Medical Sciences and Management. Bioengineering. Assessed acquisition opportunities and evaluated new revenue models.upenn.D. Managed internal teams and external relationships for up to 8 concurrent client engagements.shather.D. UK M. 25 . Launched San Francisco office as day-to-day leader. and built investment models. Philadelphia. 2009-2010 Commercial and business development consultant for life sciences organizations. New York. Summer 2014 Constructed business plan and projection model for a contemplated behavioral health product offering.upenn.2B biotechnology company. Life Technologies. Morgan. NY Associate. 2005-2007 Provided sales and marketing strategic advice to top pharmaceutical and biotechnology companies. Researched industry landscape. gaining approvals for 5 initial investments (1 healthcare services company). and mezzanine private equity investments for Direct Investment Group with ~$1. industry leaders. Performed due diligence on investment opportunities. researched SEC filings and built detailed financial models to inform analyses and provide recommendations directly to portfolio manager. Magna Cum Laude.S.edu Boston University – School of Management.000+ companies.S.g. Boston. 2007 Safeguard Scientifics. Corporate Strategy . identifying 20+ investment opportunities. Summer 2014 Worked with founding partner of healthcare-focused growth equity fund to manage due diligence process for an investment in the roll-up of several healthcare services companies. 2005-2006 Associate.. Evaluated 150 new opportunities and performed due diligence.. its themes. Longitude Capital. An opportunity to further innovation in healthcare technology. An opportunity to research and evaluate investments in public and private health care companies. developed financing materials to raise capital and worked directly with management teams. 2004-2005 One of seven undergraduates recruited nationwide for executive development program with rotational assignments. surgery centers. anesthesia. Boston. Biological Engineering. diagnostics. Valo Group. Summer 2014 Built the foundation and investment strategy for the $710M firm’s newlyformed health IT vertical.wg15@wharton. CA Summer Associate. created financial analyses and presented 13 prospective investments to Investment Committee. NJ Corporate Finance Specialist. Built financial models and cap tables. long / short hedge fund. Financial Leadership Program. Completed 2 follow-ons and refinancing for ReCommunity. 2006 – 2008 Provided financial advisory services to public and private health care clients regarding mergers.. 2011-2013 Sourced. AT&T Corporate. daniel. creating the largest independent recycling company in the U. medtech. London. acquisitions. Ithaca. radiology. and its 1. merger and leveraged buyout analyses for M&A transactions and debt and equity financings for life sciences companies. 2009 tejus. UK / New York.den. Proactively sourced 8 investment opportunities and performed due diligence. and investors.Tejus B.edu Cornell University. Davidson. and group physician practices). Business.5B dedicated capital. DC Summer Associate. whether as an investor or operator. Active board involvement on 3 portfolio companies.. divestitures/carve-outs and joint ventures. Drafted investment memos and term sheets.van. New
[email protected]. NC B. confidential media technologies for CEO.swearingen.upenn. evaluated and monitored growth equity.upenn. discounted cash flow. NY B. and health IT.S. Worked directly with partners and managed two junior interns. Ujjani laura.wg15@wharton. NY Associate. 2011-2013 Performed 8 venture capital deployments and an exit totaling $850M+ in transaction value in biopharma. European and emerging markets. accretion/dilution. Swearingen Deloitte Corporate Finance (Health Care & Life Sciences Practice). NY Vice President. MA B. HarbourVest Partners.upenn. 2004 An opportunity to build successful businesses through health care focused private equity investing. Managed a team of analysts. PA Investment Analyst Intern. . Summer 2014-Present Evaluated equity and credit investments in both health care and retail companies for value-oriented. Economics. Wells Fargo Securities. Citigroup. Philadelphia. 2009-2011 Top 10% of analyst class. Created and executed a thesis-based deal sourcing effort by mapping the sector. Rebuilt the firm’s backbone capital deployment and returns model. New York. van den Bergh Laura G.ujjani. 2008 – 2011 Analyst. 2009-2011 Led cross-border M&A transactions for private equity and Fortune 500 clients in pharma and medtech. Built financial model. Analyzed companies using comparable company. Strategic Venture Fund – Built valuation models and evaluated startup companies as potential investments for AT&T’s venture capital fund. dialysis. Performed market sizing. Wayne. Led deal team in advising not-for-profit health care system ($7B Revenue) in execution of multiple acquisitions and joint ventures (e. David Dorman.S. EuroConsult. NaviMed Capital. 2011 – 2013 Associate. Charlotte. NY Analyst.bergh. buyout. Worked with leadership of portfolio companies on strategic projects. PA Associate.edu Davidson College. MA Direct Investment Associate. Bedminster. radiation oncology.Supported Director in analyzing business models around new. Established the vertical’s advisory network of 20+ former entrepreneurs. Washington. Menlo Park. 2007-2009 Active participant on deal teams originating and executing M&A transactions in the healthcare sector across the U. NC Healthcare Investment Banking Analyst. 26 Daniel P. content design. analysis. Conducted cost savings strategies worth as much as $65M annually recurring savings. MA Summer Analyst. MA Summer Equity Analyst..yovovich. 2009-2013 Advised leading pharmaceutical and biotech clients on growth strategies. particularly at the point of service. Worked collaboratively to integrate the perspectives of a comprehensive variety of stakeholders throughout the academic medical center.. The Children’s Hospital of Philadelphia. and pricing and reimbursement strategies. 2010 rada..yang.upenn. assessment. UK and Germany. 2013 Business Analyst. and impact of generic competition. Economics. Constructed financial models and performed detailed analyses by developing bottom-up forecasts to assess sensitivity to key drivers and to identify upside/downside potential of investment opportunities. local partnership). Coordinated a global project on real-world outcomes across US.edu Yale University..g.g. clinical and non-clinical process improvement. implementation.000 physicians. Watertown. Delivered performance improvement reports. Philadelphia. Wagner Ying Yang Rada Yovovich david. 2007 M. and communication strategy. Extensive field experience with sales representatives and physicians.A.edu University of Chicago. licensing).. sales force effectiveness. Boston. potential biosimilar competition. including implementation plans and detailed impact projections to organizations ranging from 2-physician practices to 93-hospital health systems. B. supply chain.. therapeutic area strategies. and ongoing monitoring efforts. 2011-2013 Supported senior leadership team as strategic subject matter expert on revenue cycle big data performance measurement. Fidelity
[email protected]@wharton. New Haven. Analysis influenced senior decision making. PA Summer Intern.upenn. including identification. Summer 2014 Helped with 5-year strategic planning across all divisions and geographies in Novartis. with experience in big data analytics. and reporting across athena client base representing over 50. Huron Consulting Group.A.5B in assets. Chicago IL AB Fundamentals: Issues & Texts. Constructed buy/sell recommendations for four stocks and pitched them to portfolio managers. New York. 2009 ying. McKinsey & Company.A. Awarded 2011 Putnam MVP honor as distinction of top performance out of all employees. An opportunity in strategy or business development to bridge developed and emerging markets in the healthcare industry. 2006 A direct investing opportunity with exposure to the healthcare sector. and strategic sourcing cost management strategies to senior leadership teams at client health systems ranging from single hospitals to 70facility national healthcare institutions. including a needs assessment. Economics.edu Fudan University. Novartis AG.A. MA Senior Manager.upenn. Summer 2013 Member of investment team at longshort equity hedge fund with over $3. Putnam Associates. delivery model. ranging from nurse and physician staff to the senior leadership team. business development (e.David S. An opportunity focused on innovation in health care delivery. changed forecast. in both international and domestic markets. 2014 Worked with the VP of Medical Affairs to develop a program for physician leadership education. M&A target screening. athenahealth. Economics. materials management. 2006-2011 Delivered supply chain. Switzerland MBA intern. Key projects included commercial excellence (e. China B. and shifted spending. Shanghai. Focused on multinational pharmaceutical companies. Law. CT B. IL Manager.. entry and expansion strategy. MA Consultant. PAR Capital Management. and emerging market strategy (e. marketing strategy). Brazil.g. 27 .wagner. Constructed financial models and Monte-Carlo simulations to forecast value of pricing and contracting strategies. Boston. NY / Shanghai China Associate. Boston. Chicago. Corporate Strategy. Basel. 2010-2012 Distinctive analyst directly promoted to Associate and the only transferee from Greater China to the US in 2012. Developed and presented industry overview presentation of discount retail sector to portfolio managers and President of Equity Division.wg15@wharton. and revenue cycle. Summer 2014 Performed fundamental equity analysis on domestic stocks in the retail sector. MA GENZYME. CA MCKINSEY & COMPANY Palo Alto. 2014. NY DAVITA HEALTHCARE PARTNERS Denver. CA WELLS FARGO SECURITIES San Francisco. PA WALMART ECOMMERCE San Bruno. PA THE BOSTON CONSULTING GROUP Shanghai. MORGAN San Francisco. CA UNIVERSITY OF COLORADO. NY CRESSEY & CO. MA GENENTECH INC. GA KING STREET CAPITAL MANAGEMENT London. Waltham. CT GOOGLE Mountain View. CA UNIVERSITY OF PITTSBURGH MEDICAL CENTER Pittsburgh. MN 28 UNIVERSITY OF PENNSYLVANIA HEALTH SYSTEM PHILADELPHIA. CA BANK OF AMERICA MERRILL LYNCH Palo Alto. CA Washington. South San Francisco. NY TELADOC Greenwich. PA BRISTOL-MYERS SQUIBB Plainsboro. CA Minneapolis.P. NJ ATHENAHEALTH Watertown. AETNA ACCOUNTABLE CARE SOLUTIONS Boston. CA BECTON DICKINSON Franklin Lakes. MA AUGMEDIX San Francisco. China HOSPITAL OF THE UNIVERSITY OF PENNSYLVANIA. Horsham. DC APPLE TREE PARTNERS Princeton. Chicago. CA KAISER PERMANENTE Oakland. NJ BIOGEN IDEC Cambridge. MA BOOZ & COMPANY (NKA STRATEGY&) New York. GA Moscow. CENTER FOR SURGERY AND HEALTH ECONOMICS Philadelphia. NY CORNERSTONE INVESTMENT PARTNERS Atlanta. MA RAYMOND JAMES Nashville. NJ CELGENE CELLULAR THERAPEUTICS Warren. MA Hartford. CO NAVIMED CAPITAL Washington. PA CITADEL INVESTMENT GROUP New York. A SANOFI COMPANY Cambridge. NY NOVARTIS AG Basel. Switzerland FIDELITY INVESTMENTS Boston. NJ INFOSYS LIMITED Pune. Russia MEDTRONIC Northridge. NJ THE CHILDREN’S HOSPITAL OF PHILADELPHIA Philadelphia. CA ZALORA Jakarta. TN GLENHILL CAPITAL New York. CA CELGENE CORPORATION Summit. CA JOHNSON & JOHNSON – JANSSEN BIOTECH INC. CT ALBRIGHT STONEBRIDGE GROUP Washington. Indonesia CEDARS-SINAI HEALTH SYSTEM Los Angeles. NY HEALTH ESSENTIALS LLC Santa Ana. UK LONGITUDE CAPITAL Menlo Park. IL VALO GROUP Philadelphia. CA QUANTIA INC. CO HEALTH ENTERPRISE PARTNERS New York. PA . PA PUTNAM INVESTMENTS Boston. DC Atlanta. DC DELOITTE CONSULTING New York. India CASTLIGHT HEALTH San Francisco. MA PFIZER New York. CA J. PA VALENCE HEALTH Chicago. IL MOUNT KELLETT CAPITAL MANAGEMENT New York. DEPARTMENT OF MEDICINE Aurora.2014 Internship Sponsors The following organizations provided internships for Health Care Management Students in Summer. NY FITLY Philadelphia. WA DANIEL BRANCO Founder & CEO DMBranco Healthcare Investments & Advisory/Medicinia Digital Medicine São Paulo.. MD Associate Professor of Medicine & Radiology George Washington University Washington. CAMPBELL Principal SV Life Sciences Advisors. Inc. CA THIERRY CHAUCHÉ Executive Director. VA ERIC BELL Senior Director Intellectual Ventures Seattle. Inc. Kearney Mexico City. Business Development DAVITA HEALTHCARE PARTNERS Chicago. Strategy & Operations. TX continued on next page 29 . Mexico SHEENA ASHOK Senior Consultant Kaiser Permanente-Southern California Permanente Medical Group (SCPMG) Pasadena. MA NICOLE CARKNER Executive Director Quad City Health Initiative Davenport. CA JOHN BRODSKY President Fairmount Capital Advisors. MD Chief Medical Officer UnitedHealthcare Community Plan of Texas Houston. Business Development Sage Therapeutics. Melbourne. Therapeutic Area Lead Takeda Pharmaceutical Company Cambridge. IA ALI BEHBAHANI. MD CEO Consonance Capital New York. LLC (portfolio company of New Capital Partners) Denver. Market Planning Seattle Genetics Bothwell. CHOI. PA LUCAS BUCHANAN Executive Vice President. MD Partner NEA Chevy Chase. DESHPANDE. Business Planning & Analysis Novartis Pharmaceuticals East Hanover. MA JAMIL BEG Director. Executive in Residence Silk Road Medical. Inc. Warburg Pincus Sunnyvale. CA DANIEL J. Accountable Care Solutions Aetna Boston. IL RYAN COCHRAN Associate New Leaf Venture Partners New York. DC PETER R. NY ELIZABETH J. MA SALIL V. Corporate Development and Commercialization. RI ALEXIS BERNSTEIN Director. TX GRANT BECHTOLD Vice President of Business Operations / Corporate Development Medsurant Holdings. MA DEEP CHARAN. MD Resident Physician UCLA Los Angeles. NJ MITCHELL BLUTT. CA TONY BALDA President & COO Medicomp. CO RYAN BERGER Senior Business Analyst Hearst Health Innovation Lab Los Angeles. DC MEGAN UNTALAN BARKETT Chief of Staff to CEO The Advisory Board Company Washington. Cambridge. CA WILLS CHANDLER Vice President of Health System Alliance CVS Caremark Cumberland. MA CAROLYN COLACICCO Senior Manager TriVascular Santa Rosa. CA DEEPA BHAT Product Manager Genentech South San Francisco. LLC Boston. DMD President Star Ranch Dental Plano. CA VIKRAM D. MD Chief Medical Officer First Opinion San Francisco. WA BRIAN G. CURRAN. BAKHRU. Philadelphia. FL JOHN BARKETT Director of Product Marketing and Policy Affairs Towers Watson Exchange Solutions Washington. Inc. SEBASTIAN AGUILAR GARCIA Associate A. CA ALEX BUZIK Managing Director MTS Health Investors New York. MA JAY DESAI Entrepreneur PatientPing Boston. CA SAM BRASCH Director Kaiser Permanente Ventures Oakland. Brazil MARK CHIN Vice President Longitude Capital Menlo Park.T. MD Vice President. BARNETT. NY BRETT COHEN Corporate Vice President Fresenius Medical Care Waltham. NY EMILY COUEIGNOUX CHEN Senior Manager. DC EDDIE CISNEROS Vice President. MD EDWARD CHAN Senior Associate NaviMed Capital Rosslyn.2014 Health Care Program Mentors Mentors are leaders and senior managers in the health care field who have agreed to provide career and professional development advice and guidance to Health Care Management Students. LLP Parsippany. Conshohocken. GA EVAN S. MD Executive Vice President and Chief Operating Officer UNC Hospitals Chapel Hill. Brazil BRIAN P. PA TRACY K. MD Assistant Professor of Pediatrics. NY . PA CHRIS DUKE Executive Director International Commercial Relations NPS Pharmaceuticals Bedminster. NY TODD HOLMES Director Gurnet Point Capital Boston. MD Partner InterWest Partners Menlo Park. Corp. PA JARED HOPKINS Director Strategic Finance and Business Consulting University of Michigan Health System Ann Arbor. CA MING FANG Principal Safeguard Scientifics. NJ CATHY K. Corporate Development & Strategy Everyday Health New York. Director Care Model Innovation.Brazil Office Rio de Janeiro. TX BRANDON EINSTEIN Associate Goldman Sachs New York. OR MAGGIE HILL JARRETT Senior Manager. New York. MD Partner SR One Ltd San Francisco. NY RAMI ELGHANDOUR Chief Business Officer Nevro Menlo Park. Healthcare Venture Investments AVIA Innovation Accelerator Chicago. Chicago. CO PHILIP GUTRY Principal MPM Capital South San Francisco. Manager.Health Care Program Mentors PITAMBER “PITOU” DEVGON. Life Sciences & Health Care Deloitte Consulting. a subsidiary of Aetna New York. CA JOHN HARRIS Principal DGA Partners Bala Cynwyd. PA FABIO ALEXANDRE JUNG Director/Investment Banking Brazil Deutsche Bank São Paulo. Brazil KARL M. Inc. Philadelphia. IL MICHAL GATTNAR Managing Director Pavis Capital Mill Valley. Diversified Businesses Allegheny Health Network Pittsburgh. GEORGE. Inc. GOLDSTEIN. Attending Physician General Pediatrics. Global Franchise Leader CardioVascular GlaxoSmithKline Brentford. Inc. CA DAVID HECHT Vice President Formation Capital Alpharetta. Business and Commercial Development Tetralogic Pharmaceuticals Malvern. NY DOUGLAS C. EDDY President Health Plan Alliance Irving. NY EMILY COOPER JANVEY Vice President TPG Special Situations Partners San Francisco. Strategy and Business Development McKesson San Francisco. FISHER. Inc. MI NOUHAD HUSSEINI Senior Director. Santa Rosa. NJ 30 SARAH FREW Director. CA SIMEON J. NC VIKAS GOYAL Associate SR One Cambridge. KELLNER Director McKinsey & Company. IL MIHIR C. CA PRASHANTH JAYARAM Healthcare Analyst Citadel Group New York. MA BRIAN HOLZER Senior Vice President. IL PHIL HEIFETZ President and CEO EyelC. NJ DANIEL FAGA Principal Centerview Partners San Francisco. The Children’s Hospital of Philadelphia Philadelphia. PA MICHAEL FAZEKAS Vice President Flexpoint Ford. W. NY BOSUN HAU Partner MVM Life Science Partners Boston. Business Development Regeneron Pharmaceuticals Tarrytown. Corporate Strategy & Business Development McKesson Denver. MD Senior Vice President. CA KYLE GILBRIDE Senior Associate HEALTHAGEN. JAYARAMAN Vice President – Global Sales & Marketing TriVascular. Wayne. Perelman School of Medicine. MA VIVEK K. LLC Chicago. JOHNSON Vice President Health Strategies and Solutions Philadelphia. MD Co-Founder Creative Vascular. CA AARON FLINK Sr. FIELDSTON. Inc. GANDHI Director. NY LETICIA LAZARIDIS GOLDBERG Investment Management Earnest Partners . Inc. CA MYRIAN EXUME Director. PA CHRIS FRANCK Partner. CA TODD GUREN Product Development Manager Providence Health Plans Portland. PA CARRIE HIEBELER Senior Investment Officer Ventas. MA VLAD HOGENHUIS. UK SAM HOLLIDAY Vice President. PA PETER FISHMAN Founder Tolograph New York. Global Commercialization Bristol-Myers Squibb Princeton. KOPPEL. MO TATIANA NIKITINA Chief Marketing Officer xG Health Solutions New York. CO DAVE KONCIAK Director. MA MICHAEL LI Portfolio Manager American Century Investments Kansas City. WA RUHI KHAN Vice President. MA continued on next page 31 . CA STEPHEN KIM Associate Goldman. PA LISA RAMON Health Systems and Services Expert for Latin America McKinsey & Company Mexico City. MD Assistant Professor Weill Cornell Medical College New York. NASH. LYLES. VA CARY PFEFFER. MA JEFFREY D. CA JOYCE KIM Senior Managerial Consultant Kaiser Permanente Ventures Oakland. KERO Vice President. PA JOHN PICASSO Senior Associate Fifth Street Management LLC White Planis. CT JAMES O’CONNELL Principal Safeguard Scientifics. SC JENNIFER O’NEILL Brand Manager. PA PRASHANT NIKAM Director. OH ADAM LESSLER Engagement Manager McKinsey & Company Philadelphia. IL HAREESH NAIR Vice President Quadria Capital Investment Mgmt. New York. Indianapolis. PA MIKE KIJEWSKI Founder Gamma Basics Carlsbad. Atlas Venture. Dept. MD Senior Vice President and Chief Strategy Officer Mallinckrodt Pharmaceuticals Hazelwood. PA ERIC REDLINE Vice President Client Delivery Pharma Metrics Fort Washington. CA LINDSAY RAND Senior Manager. Jefferson School of Population Health Thomas Jefferson University Philadelphia. Acute Care Universal Health Services King of Prussia. Business Development & Operations VHA West Coast Insurance & Financial Services Renton. Pte Ltd Singapore KEVIN PYUN Managing Director Consonance Capital Investors New York. NY DAVID KIBBE Divisional Vice President. NY OSCAR LIN Analyst Axial Capital New York. PA GARY M. CA RICHARD LEE. MO ALISON MARX Operating Officer. MD Partner Third Rock Ventures Boston. Inc. IL DONNA BRADY RAZIANO. MD Dean. PHILLIPS. CA WESLEY NURSS Associate ISI Group New York. of Pediatrics The Children’s Hospital of Philadelphia Philadelphia. Inc. NY ROBERT C. Payer Strategy & Operations Evolent Health Arlington. IN LEN PODOLSKY Director of Operations Connolly. NY LAUREN LISHER Senior Director RelayHealth/McKesson Corporation Emeryville. MARRAZZO President and CEO Spark Therapeutics Inc. MA MICHELLE LEE Consultant Kaiser Permanente Performance Excellence San Francisco. Ataxion Therapeutics Cambridge. NY PRIYA NILEKANI Senior Managerial Consultant Kaiser Permanente Oakland. Strategic Initiatives Office University of Chicago Medicine Chicago. NY SALLY POBLETE Founder and CEO Wellthie Inc. Effient Daiichi Sankyo Inc. Sachs & Co. NJ ADAM M. Philadelphia. PA JOSHUA RESNICK. IL AMIKA PORWAL Senior Associate Booz & Company Chicago. Mexico TY NELSON Executive Vice President Operations Health Carousel LLC Cincinnati. NY WENDY LIU Vice President HealthCare Royalty Partners Stamford. LLC Conshohocken. NY GREGG MCCONNELL Sr. PHD Chief Strategy Officer & Senior Vice President Biogen Idec Boston. Mercy Home and Community Health Services Philadelphia. PA MARK A. MD President Aledo Consulting. CEO. MD Vice President Nomura New York.RON C. Mozobil & Legacy Brands Sanofi Cambridge. Wayne. PA REGAN MURPHY Chief of Staff / Client Manager Valence Health Chicago. NY RYAN KIRKPATRICK Partner Colorado Impact Fund Denver. MD Chief Strategic Officer Medical University of South Carolina Charleston. New York. Business Development Pfizer New York. MD. MCDONALD. Parsippany. Global Commercial Leader. Strategic Analytics Bristol-Myers Squibb Lawrenceville. NJ CAROLYN MAGILL Senior Vice President. MD Chief Medical Officer Mercy Home System. NY ELIZABETH LEIDERMAN. MD Venture Partner. Business Development Acorda Therapeutics Hawthorne. Manager. NY DAVID B. NY JAMES STANFORD Principal Fitzroy Health Upper Montclair. Brillinta AstraZeneca Wilmington. Business Development SciClone Pharmaceuticals.BEN RHEE Senior Manager – Life Sciences Strategy Accenture Philadelphia. LLC New York. NY EDMONDO J. WONG Vice President. Health and IT Strategy West Health Institute La Jolla. Program Officer California Health Care Foundation San Francisco. Sweden DAVID SCHUPPAN Partner Cressey & Company LP Chicago. TX JAMES F. Market Access and Patient Services BioMarin Pharmaceutical Inc. NY PATRICK SULLIVAN Vice President GMT Capital Corp. PA JAMES RHODES Senior Consultant Deloitte Consulting LLP Dallas. Irvine. San Francisco. NY BENJAMIN ROOKS Managing Director ST Advisors. RIZVI Managing Director UCB India Private Limited Mumbai. CA MICHAEL ROVINSKY Executive Director. GA SHAFINA SHEHNAZ Vice President Goldman Sachs & Co. CT LISA VARSHNEY Associate Partner Rosetta Marketing Strategy & Insights Practice New York. NY JOHN WINKELMAN President Winkelman Associates Inc. CA VIC TANDON Sr. NY STEPHEN E. NH JASON WEIDMAN Vice President and General Manager. NJ ELLEN S. Inc. Bus. Strategic Planning Kaiser Permanente of the Mid-Atlantic States Rockville. RICHTER Vice President Business Development RedMed Paoli. NJ MEIR STEIN Director of Marketing Development Satellite Healthcare San Jose. Commercial Clinical Strategy & Analytics WebMD/Medscope New York. Inc. Ambulatory Care Universal Health Services. New York. Global Oncology Franchise GlaxoSmithKline Collegeville. NY JONTHAN SOLOMONS President & CEO Tabor Children’s Services Philadelphia. ROBINSON. Dev. DE . YOON Global Health Care Subject Matter Expert IBM Corp. US Marketing Pfizer New York. India PAMELA RODMAN Administrative Director Columbia University New York. China DANIEL YIP Senior Director. Bristol-Myers Squibb Princeton. GA ANNE SISSEL Vice President Dean Bradley Osborne San Francisco. YODER. CA JARED TEO Sr. Global Marketing Intercept Pharmaceuticals New York. DE BHUVAN SRINIVASAN Associate KKR Mumbai. CA PAUL V. NY ANKIT SHAH Sr. CV/Metabolic Search & Evaluation. THOMAS Business Unit Head – Biosimilars Biocon Ltd. PA AMANDA HOPKINS TIRRELL Chief Operating Officer Georgia Regents Medical Associates. CA ANDREW W. MD Associate Principal McKinsey & Company New York. King of Prussia. Bangalore. CA CHRIS WILKERSON President EquipSystems. NY KEELY ZIPP Director Oncology Operations. France SCOT STEVENS Public Equity Partner Orbi Med Advisors LLC New York. New York. Physician in Chief Christiana Care Health System Wilmington. Novato. Inc. SHAH. PA SAFIA K. NY RUTH SUTER Senior Director. India MAUREEN A. NY 32 DAVID SILK Director Digital Acceleration. Manager. CA JONATHAN SHANNON Executive Director Universal American (Collaborative Health Systems) Atlanta. MD Global Lead. NY DAVID WALTON Chief Commercial Officer AgaMatrix Salem. Medtronic Coronary Vascular Medtronic Santa Rosa. SPIVACK Managing Director KPMG Corporate Finance LLC New York. CA JÉRÔME STEVENS. MD ANIL SAGGI M&A Director Novartis Stockholm. CA ERIC TRÉPANIER Vice President. PA JOHN URQUHART Senior Associate HealthCare Royalty Partners Stamford. MD Associate Chief Medical Officer. India PAUL TIRJAN Vice President. Medical College of Georgia Augusta. New York. Marketing Manager Intersect ENT Menlo Park. PA THOMAS ZIPP Global Brillinta Business Insight Lead. IL SVEN SEYFFERT Senior Business Director Medtronic Singapore AMIT B. Shanghai. MD CEO Patientys (subsidiary of Direct Medcica Group) Boulogone. MBA Program in Health Care Management CHRISTINE ALESZCZYK Administrative Coordinator. HARRINGTON. GARRETT. KINNEY. PH. The Wharton Graduate Division SCOTT E. Vice Dean and Director. PH. The Wharton School HOWARD KAUFOLD. MBA Program in Health Care Management JUNE M.A.D.D. Chair. M. MBA Program in Health Care Management JANICE SINGLETON Administrative Coordinator. Dean. Associate Director. The Wharton School. MBA Program in Health Care Management 33 . Director.Administration GEOFFREY M.D. PH. Health Care Management Department. Lecturer.S. BURNS. Professor of Medicine. PH. Professor. PH.D. PH. PH. The Wharton School JONATHAN T. Walgreens. Lecturer. The Wharton School. M. J. Celia Z. M. Chief Executive Officer. Professor. Health Care Management.. Professor of Health Care Management. Lecturer.D. Penn Medicine Center for Health Care Innovation.P.D.D.P. PH. Health Care Management. Professor. Henry Bower Professor of Entrepreneurial Studies. PH.A. Perelman School of Medicine at the University of Pennsylvania. PH. Senior Fellow. Health Care Management. PIERSKALLA. PATEL. Executive Director.D. Professor. ASCH. Assistant Professor. PH. Diane v.. Health Care Management. Health Care Management. LIBSON. Professor.D. The Wharton School DAVID A. Vice President. Graduate Program in Health Care Management.D. PH. The Wharton School GARY J. The Center for Applied Research Inc. Health Care Management. PH. Associate Professor. The Wharton School. Faculty Co-Director. Business Economics and Public Policy. CEO and Chairman.. The Wharton School. and Health Care Management.D. The Wharton School JOHN KIMBERLY. M. Professor of Medicine. and Sociology. The Wharton School MATTHEW R. BAKER.P. Lecturer. Lecturer. The Wharton School NAOKI IKEGAMI.D. the School of Medicine. President and CEO. The Wharton School STEVEN A...B. College of Arts and Sciences WILLIAM P. Perelman School of Medicine at the University of Pennsylvania. Miller Professor of Health Care Management and Business Economics and Public Policy. Chair.D. Professor. GLASER. Health Care Management. Roy and Diana Vagelos Program In Life Sciences & Management PATRICIA M. Avalere Health Inc. PH. Professor.B. M. Lecturer. University of Pennsylvania Law School.. Eilers Professor of Health Care Management and Economics. Japan. PH. The Wharton School JUNE M.Faculty The Program Faculty are drawn from the Wharton School. M. the School of Nursing. Moh Professor of Health Care Management and Business Economics. Health Care Management. Professor of Management. PH. Siemens.D. Health Care Management Program. PH. PH. Bocconi University Graduate School of Management. M.D. Bendheim Professor. M. The Wharton School BRADLEY M. KURTZMAN. KINNEY.H. The Wharton School THOMAS E.A. Anheuser-Busch Professor Emeritus of Management Science. MENDELSON. Health Care Management. The Wharton School JEFFREY P. M.D. Professor of Law at the Earle Mack School of Law and Professor of Health Management and Policy at the School of Public Health at Drexel University. Levy University Professor and Vice Provost for Global Initiatives.D. Life Sciences. The Wharton School HARI MAHADEVAN. Assistant Professor of Health Care Management. Lecturer. The Wharton School DANIEL N. Health Care Management. Milan. Tokyo.B. The Wharton School MARK V. Health Care Management. NICHTBERGER. The Wharton School 34 EZEKIEL J.D. GRENNAN. Perelman School of Medicine at the University of Pennsylvania School of Medicine.ARCH. and Thomas L. Adjunct Professor and Senior Fellow. Health Care Management. Health Systems Business Unit. Partner. The Wharton School ROBERT I. Italy. Lecturer and Senior Fellow.D. Leonard Davis Institute of Health Economics . The Wharton School JOHN C. William Maul Measey Professor of Law and Health Sciences..D. John M. The Wharton School LAWTON R. Health Care Management. Independent Consultant.D. Additional support is provided by the Fellows and Associates of the Leonard Davis Institute of Health Economics. James Joo-Jin Kim Professor of Health Care Management.D. EMANUEL.D.D. M. The Wharton School SCOTT E. The Wharton School THOMAS N.A. Health Care Management Department. GLICK. The Wharton School Alan B. Senior Fellow. HERSHEY. Executive Director. Pepper Hamilton LLP.D. EUGENIO ANESSI. The Wharton School GUY DAVID. J. KOLSTAD.D. and Director.. M. Economics.A. Assistant Professor. Health Care Management. Vice President. Perelman School of Medicine at the University of Pennsylvania. M. DANZON. The Wharton School JOHN P. Robert D. Health Care Management. Public Management. Philadelphia. Associate Director. Integral Molecular. Assistant Professor of Medicine. PH. Senior Fellow. Health Care Management. Professor Emeritus DANIEL POLSKY.D.. The Wharton School BENJAMIN DORANZ. FIELD. M. PH. Health Care Management. FLUEGEL Senior VP & Chief Strategy Officer. Keio University School of Medicine. and the School of Arts and Sciences at the University of Pennsylvania and leading health institutions in Philadelphia. The Wharton School MITESH S. J. Health Care Management The Wharton School HENRY A. PH.D. Professor of Medicine. Levy and Robert M. Safeguard Scientifics. Lecturer and Senior Fellow. M.D. Health Care Management. HARRINGTON. Inc. PAULY.D. Health Care Management. GILMORE. Health Care Management. PH.D. The Wharton School STEPHEN M. scholarship and loan awards.B.N. MBA Program in Health Care Management. Center for Outcomes Research. The Wharton School J. Health Care Management. Professor.D. The Wharton School JEFFREY A. disability. PH. Operations and Information Management. The Wharton School RACHEL M. All rights reserved. Health Care Management. religion. M. M. The Wharton School ASHLEY SWANSON. or status as a Vietnam Era Veteran or disabled veteran in the administration of educational policies. M. Health Care Management.B. Director.D.A.D. sex.D. Leonard Davis Institute. The Wharton School SANKEY V. Professor of Pediatrics and Anesthesiology & Critical Care.D. The TRECS Institute. Center for Health Incentives and Behavioral Economics. PH. Professor Emeritus of Nursing and Health Care Management. Health Care Management The Wharton School KEVIN G.D. Health Care Management.M. athletic. Professor. Director. Perelman School of Medicine at the University of Pennsylvania. Sol Katz Professor of General Internal Medicine. Lecturer.D. The Wharton School JEFFREY H. SOLOMON. age.D. Professor of Medicine. Assistant Professor. Lecturer. SILBER. Health Care Management. Suite 228 Philadelphia. PH. The Trustees of the University of Pennsylvania. admissions policies. Entrepreneurial Programs. TOWN. WERNER.. M. M. or other University administered programs or employment. Assistant Professor. color.. PH. Health Care Management. The Wharton School JOHN J.A. Health Care Management. M. J. The Wharton School Questions or complaints regarding this policy should be directed to: Executive Director. SAMMUT Lecturer and Senior Fellow. Perelman School of Medicine at the University of Pennsylvania School of Medicine. MBA Program in Health Care Management The Wharton School AMANDA STARC. Infiniti Medical LLC.B. Leon Hess Professor in Internal Medicine. PA 19104-6106 215. The Wharton School The University of Pennsylvania values diversity and seeks talented students.6993 (Voice) 215.7803 (TDD) ROBERT J. The Wharton School CYNTHIA SCALZI. sexual orientation. Associate Professor and Senior Fellow. PH. M. Independent Consultant. Executive Director. programs or activities. The Children’s Hospital of Philadelphia. Photography of Students: Stuart Watson Book Design: www. The Wharton School JUNE KINNEY Associate Director. WILLIAMS.com 35 . Lecturer. Perelman School of Medicine at the University of Pennsylvania. Health Care Management. The Wharton School ARNOLD J. M.D. Perelman School of Medicine at the University of Pennsylvania. HARRINGTON.D Associate Professor of Medicine. Health Care Management.D. PH. WHITMAN.HollisterCreative. M.. Professor Emeritus.D.D. faculty and staff from diverse backgrounds.A. Professor.898. Professor. Director. PH. ROSOFF. Health Care Management. Founding Partner. Health Care Management.D. M. national or ethnic origin. Associate Professor. The University of Pennsylvania does not discriminate on the basis of race. The Wharton School ©2004.DOUGLAS A. gender identity. VOLPP. SANFORD SCHWARTZ.. Legal Studies and Business Ethics. Lecturer.. Lecturer. Health Care Management. SCOTT E.898. PRESENT. Office of Affirmative Action and Equal Opportunity Programs Sansom Place East 3600 Chestnut Street. 6861 fax 215.Wharton The Wharton School University of Pennsylvania MBA Program in Health Care Management 3641 Locust Walk Philadelphia.2157 .573.898. PA 19104-6218 215.